[[1, [[[501.0, 36.0, 41, 7], "PERSPECTIVE"], [[458.0, 44.0, 78, 7], "published: 30 November 2021"], [[450.0, 52.0, 85, 7], "doi: 10.3389/fcimb.2021.798563"], [[175.0, 159.0, 347, 24], "Fighting Staphylococcus epidermidis"], [[175.0, 181.0, 283, 24], "Bio\ufb01lm-Associated Infections:"], [[175.0, 205.0, 310, 24], "Can Iron Be the Key to Success?"], [[175.0, 238.0, 308, 16], "Fernando Oliveira 1, Holger Rohde 2, Manuel Vilanova 3,4,5 and Nuno Cerca 1*"], [[175.0, 259.0, 314, 11], "1 Centre of Biological Engineering, Laboratory of Research in Bio\ufb01lms Rosa\u00b4 rio Oliveira (LIBRO), University of Minho, Braga,"], [[175.0, 270.0, 290, 11], "Portugal, 2 Institut f\u00fcr Medizinische Mikrobiologie, Virologie und Hygiene, Universit\u00e4tsklinikum Hamburg-Eppendorf,"], [[175.0, 279.0, 301, 11], "Hamburg, Germany, 3 Instituto de Investigac\u00b8\u00e3o e Inovac\u00b8\u00e3o em Sau\u00b4 de (i3S), Universidade do Porto, Porto, Portugal,"], [[175.0, 289.0, 322, 11], "4 Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal, 5 Instituto de Cie\u02c6 ncias Biome\u00b4 dicas"], [[175.0, 300.0, 174, 7], "de Abel Salazar, Universidade do Porto (ICBAS-UP), Porto, Portugal"], [[125.0, 398.0, 28, 7], "Edited by:"], [[106.0, 408.0, 45, 7], "Brendan Gilmore,"], [[78.0, 418.0, 68, 7], "Queen\u2019s University Belfast,"], [[110.0, 428.0, 41, 7], "United Kingdom"], [[114.0, 442.0, 38, 7], "Reviewed by:"], [[112.0, 452.0, 39, 7], "Pietro Speziale,"], [[88.0, 462.0, 60, 7], "University of Pavia, Italy"], [[84.0, 472.0, 64, 7], "Christian Johann Lerche,"], [[86.0, 482.0, 62, 7], "Rigshospitalet, Denmark"], [[98.0, 496.0, 51, 7], "*Correspondence:"], [[122.0, 506.0, 31, 7], "Nuno Cerca"], [[78.0, 516.0, 69, 7], "nunocerca@ceb.uminho.pt"], [[100.0, 539.0, 50, 7], "Specialty section:"], [[72.0, 549.0, 73, 7], "This article was submitted to"], [[133.0, 559.0, 22, 7], "Bio\ufb01lms,"], [[90.0, 569.0, 58, 7], "a section of the journal"], [[88.0, 579.0, 60, 7], "Frontiers in Cellular and"], [[93.0, 589.0, 56, 7], "Infection Microbiology"], [[72.0, 603.0, 74, 7], "Received: 20 October 2021"], [[64.0, 613.0, 80, 7], "Accepted: 11 November 2021"], [[63.0, 623.0, 81, 7], "Published: 30 November 2021"], [[130.0, 637.0, 24, 7], "Citation:"], [[50.0, 647.0, 92, 7], "Oliveira F, Rohde H, Vilanova M and"], [[87.0, 657.0, 61, 7], "Cerca N (2021) Fighting"], [[50.0, 667.0, 94, 7], "Staphylococcus epidermidis Bio\ufb01lm-"], [[79.0, 677.0, 68, 7], "Associated Infections: Can"], [[72.0, 687.0, 73, 7], "Iron Be the Key to Success?"], [[45.0, 697.0, 103, 7], "Front. Cell. Infect. Microbiol. 11:798563."], [[63.0, 707.0, 85, 7], "doi: 10.3389/fcimb.2021.798563"], [[175.0, 326.0, 376, 12], "Staphylococcus epidermidis is one of the most important commensal microorganisms of"], [[175.0, 340.0, 362, 12], "human skin and mucosae. However, this bacterial species is also the cause of severe"], [[175.0, 354.0, 361, 12], "infections in immunocompromised patients, specially associated with the utilization of"], [[175.0, 367.0, 342, 12], "indwelling medical devices, that often serve as a scaffold for bio\ufb01lm formation. S."], [[175.0, 381.0, 334, 12], "epidermidis strains are often multidrug resistant and its association with bio\ufb01lm"], [[175.0, 395.0, 368, 12], "formation makes these infections hard to treat. Their remarkable ability to form bio\ufb01lms"], [[175.0, 409.0, 375, 12], "is widely regarded as its major pathogenic determinant. Although a signi\ufb01cant amount of"], [[175.0, 423.0, 350, 12], "knowledge on its bio\ufb01lm formation mechanisms has been achieved, we still do not"], [[175.0, 438.0, 382, 12], "understand how the species survives when exposed to the host harsh environment during"], [[175.0, 452.0, 369, 12], "invasion. A previous RNA-seq study highlighted that iron-metabolism associated genes"], [[175.0, 466.0, 354, 12], "were the most up-regulated bacterial genes upon contact with human blood, which"], [[175.0, 479.0, 335, 12], "suggested that iron acquisition plays an important role in S. epidermidis bio\ufb01lm"], [[175.0, 494.0, 348, 12], "development and escape from the host innate immune system. In this perspective"], [[175.0, 508.0, 321, 12], "article, we review the available literature on the role of iron metabolism on S."], [[175.0, 522.0, 368, 12], "epidermidis pathogenesis and propose that exploiting its dependence on iron could be"], [[175.0, 536.0, 181, 12], "pursued as a viable therapeutic alternative."], [[175.0, 557.0, 315, 7], "Keywords: iron acquisition systems, regulation of iron acquisition, Siderophores, S. epidermidis bio\ufb01lms, role of"], [[175.0, 567.0, 44, 7], "iron in infection"], [[175.0, 603.0, 85, 13], "INTRODUCTION"], [[175.0, 625.0, 324, 10], "Health care-associated infections (HAIs) are a signi\ufb01cant cause of morbidity and mortality"], [[175.0, 637.0, 343, 10], "worldwide and represent an increasing problem in modern medicine (Haque et al., 2018). More"], [[175.0, 648.0, 359, 10], "than 4 million patients are affected by HAIs every year in Europe, with an average prevalence rate of"], [[175.0, 660.0, 361, 10], "7.1%, which accounts for an annual cost of approximately 7 billion (Allegranzi et al., 2011; European"], [[175.0, 671.0, 359, 10], "Centre for Disease Prevention and Control, 2018). In developing countries, the estimated prevalence"], [[175.0, 683.0, 357, 10], "rates of HAIs are even higher, ranging from 5.7% to 19.1% (pooled prevalence rate of 10.1%) (Pittet"], [[175.0, 694.0, 328, 10], "et al., 2008; Allegranzi et al., 2011). Patients admitted to intensive care units are particularly"], [[175.0, 706.0, 361, 10], "susceptible to these infections, not only due to their immunocompromised status, but also due to the"], [[45.0, 743.0, 171, 7], "Frontiers in Cellular and Infection Microbiology | www.frontiersin.org"], [[295.0, 743.0, 3, 7], "1"], [[408.0, 743.0, 115, 7], "November 2021 | Volume 11 | Article 798563"]], [779, 595]], [2, [[[45.0, 30.0, 32, 7], "Oliveira et al."], [[399.0, 30.0, 129, 7], "Interplay Between S. epidermidis Bio\ufb01lms and Iron"], [[45.0, 62.0, 192, 10], "extensive use of invasive procedures and devices (e.g.,"], [[45.0, 74.0, 194, 10], "mechanical ventilators and catheters) (Vincent, 2003)."], [[45.0, 85.0, 211, 10], "Bloodstream infections, surgical site infections and urinary"], [[45.0, 97.0, 223, 10], "tract infections account for the majority of HAIs (Magill et al.,"], [[45.0, 108.0, 221, 10], "2014). According to the type of infection, the causative agents"], [[45.0, 120.0, 192, 10], "may vary, although staphylococci, and in particular S."], [[45.0, 131.0, 212, 10], "epidermidis, play an important role in HAIs episodes (Zarb"], [[45.0, 143.0, 226, 10], "et al., 2012). The establishment of S. epidermidis as a successful"], [[45.0, 154.0, 216, 10], "nosocomial pathogen stems from its intrinsic ability to form"], [[45.0, 165.0, 227, 10], "bio\ufb01lms on the surface of implantable medical devices, which is"], [[45.0, 174.0, 234, 16], "often accompanied by multidrug resistance (A\u0301 guila-Arcos et al.,"], [[45.0, 189.0, 219, 10], "2017) and increased antibiotic tolerance (Dengler Haunreiter"], [[45.0, 200.0, 200, 10], "et al., 2019), rendering the treatment of HAIs extremely"], [[45.0, 212.0, 198, 10], "challenging. Therefore, a deeper understanding of their"], [[45.0, 223.0, 210, 10], "pathogenic mechanisms, particularly those associated with"], [[45.0, 234.0, 209, 10], "bio\ufb01lm formation, is, more than ever before, pivotal in the"], [[45.0, 245.0, 167, 10], "identi\ufb01cation of new antibacterial drug targets."], [[45.0, 279.0, 117, 14], "BACTERIAL BIOFILMS"], [[45.0, 301.0, 206, 10], "Our perception of how bacterial growth takes place in the"], [[45.0, 313.0, 218, 10], "environment, particularly during infection, has changed over"], [[45.0, 324.0, 228, 10], "the years. If on one hand bacteria were initially thought to grow"], [[45.0, 336.0, 198, 10], "mostly under a planktonic mode of growth, as it occurs"], [[45.0, 347.0, 213, 10], "arti\ufb01cially in a liquid culture, it is currently well-established"], [[45.0, 358.0, 228, 10], "that forming a bio\ufb01lm is the preferred mode of growth for most"], [[45.0, 370.0, 232, 10], "bacterial species (Flemming et al., 2016). The classic de\ufb01nition of"], [[45.0, 381.0, 229, 10], "a bio\ufb01lm is a structured community of microorganisms adhered"], [[45.0, 393.0, 226, 10], "to each other and/or to a surface, which is often embedded in a"], [[45.0, 405.0, 206, 10], "self-produced matrix of extracellular polymeric substance"], [[45.0, 416.0, 224, 10], "(Donlan and Costerton, 2002). Despite its frequent association"], [[45.0, 428.0, 227, 10], "with infectious diseases, this mode of growth is also adopted by"], [[45.0, 439.0, 215, 10], "non-pathogenic bacteria in different locations of the human"], [[45.0, 451.0, 220, 10], "body, such as skin (Brandwein et al., 2016) or gastrointestinal"], [[45.0, 462.0, 225, 10], "tract (De Vos, 2015). Therefore, the ability to grow as a bio\ufb01lm"], [[45.0, 474.0, 229, 10], "can be generally regarded as a way bacteria employ to cope with"], [[45.0, 485.0, 221, 10], "harsh environments (Flemming et al., 2016). In S. epidermidis"], [[45.0, 496.0, 218, 10], "bio\ufb01lm assembly follows a basic stepwise process comprising"], [[45.0, 508.0, 198, 10], "distinct stages: primary attachment of cells to a surface,"], [[45.0, 520.0, 221, 10], "accumulation of cells in multiple layers and maturation of the"], [[45.0, 531.0, 226, 10], "bio\ufb01lm structure, and detachment of cells from the bio\ufb01lm and"], [[45.0, 543.0, 134, 10], "their dispersal (Fey and Olson, 2010)."], [[45.0, 565.0, 179, 14], "S. epidermidis Bio\ufb01lms in Infection"], [[45.0, 579.0, 216, 10], "During infection, S. epidermidis face severe restriction in the"], [[45.0, 590.0, 232, 10], "availability of essential nutrients, a phenomenon usually referred"], [[45.0, 601.0, 221, 10], "to as \u201cnutritional immunity\u201d (Cassat and Skaar, 2013). Iron is"], [[45.0, 613.0, 229, 10], "one of those essential nutrients, which bacteria must acquire for"], [[45.0, 625.0, 224, 10], "their own cellular functions (Andrews et al., 2003). As a result,"], [[45.0, 636.0, 232, 10], "iron acquisition has been considered as a key process in bacterial"], [[45.0, 648.0, 227, 10], "pathogenicity (Skaar, 2010; Oliveira et al., 2021a). Interestingly,"], [[45.0, 659.0, 231, 10], "there has been increasing evidence suggesting that iron may also"], [[45.0, 670.0, 225, 10], "exert a modulatory effect over S. epidermidis bio\ufb01lm formation"], [[45.0, 682.0, 220, 10], "(Oliveira et al., 2017), although the exact mechanisms are not"], [[45.0, 693.0, 233, 10], "completely understood. Nevertheless, the study of bio\ufb01lms under"], [[45.0, 705.0, 192, 10], "iron-restricted conditions represents not only a closer"], [[306.0, 62.0, 218, 10], "approximation to the environmental conditions found in the"], [[306.0, 74.0, 226, 10], "human host, but it is also pivotal for a better comprehension of"], [[306.0, 84.0, 210, 10], "the molecular mechanisms behind bio\ufb01lm formation in an"], [[306.0, 97.0, 66, 10], "infection scenario."], [[318.0, 107.0, 219, 10], "The matrix of S. epidermidis bio\ufb01lms is a complex mixture of"], [[306.0, 120.0, 227, 10], "polysaccharides, proteins and nucleic acids. The polysaccharide"], [[306.0, 131.0, 227, 10], "intercellular adhesin (also known as poly-N-acetylglucosamine;"], [[306.0, 143.0, 241, 10], "PIA/PNAG), which biosynthesis is mediated by the products of the"], [[306.0, 154.0, 249, 10], "ica (intercellular adhesion) operon (Heilmann et al., 1996) was one of"], [[306.0, 165.0, 237, 10], "the \ufb01rst molecules found to be implicated in S. epidermidis bio\ufb01lm"], [[306.0, 177.0, 217, 10], "accumulation (Ziebuhr et al., 1997). Since then, other factors"], [[306.0, 188.0, 229, 10], "mediating intercellular adhesion and bio\ufb01lm accumulation have"], [[306.0, 199.0, 236, 10], "been identi\ufb01ed such as the accumulation-associated protein (Aap)"], [[306.0, 212.0, 247, 10], "(Rohde et al., 2005), the extracellular matrix-binding protein (Embp)"], [[306.0, 223.0, 250, 10], "(Christner et al., 2010), or the small basic protein (Sbp) (Decker et al.,"], [[306.0, 234.0, 225, 10], "2015). The matrix of S. epidermidis bio\ufb01lms has been shown to"], [[306.0, 246.0, 243, 10], "impede the penetration of antimicrobial molecules, phagocytic cells,"], [[306.0, 258.0, 232, 10], "reactive oxygen species, among others (Otto, 2012), which partly"], [[306.0, 268.0, 244, 10], "explains why S. epidermidis bio\ufb01lm-associated infections are hard to"], [[306.0, 281.0, 244, 10], "eradicate or frequently relapse. Nevertheless, the understanding that"], [[306.0, 291.0, 251, 10], "the bio\ufb01lm matrix acts solely as a physical barrier has been challenged"], [[306.0, 303.0, 209, 10], "over the years. In a study addressing bio\ufb01lms formed by S."], [[306.0, 315.0, 236, 10], "epidermidis, Staphylococcus aureus, Escherichia coli, and Klebsiella"], [[306.0, 327.0, 250, 10], "pneumoniae it was demonstrated that the ability of different classes of"], [[306.0, 337.0, 244, 10], "antibiotics to kill bio\ufb01lm cells are independent of penetration (Singh"], [[306.0, 349.0, 223, 10], "et al., 2016). Another important issue about bio\ufb01lm-associated"], [[306.0, 360.0, 222, 10], "infections is that bio\ufb01lm cells employ different mechanisms to"], [[306.0, 373.0, 234, 10], "evade the host immune response. It was previously demonstrated"], [[306.0, 383.0, 246, 10], "that the diffusion of antibodies through S. epidermidis bio\ufb01lms is not"], [[306.0, 395.0, 248, 10], "hindered by the bio\ufb01lm matrix itself, but instead antibodies penetrate"], [[306.0, 406.0, 244, 10], "the matrix and bind to speci\ufb01c receptors within the matrix (i.e. PIA/"], [[306.0, 419.0, 192, 10], "PNAG), which reduce the available antibodies during"], [[306.0, 430.0, 199, 10], "opsonophagocytosis (Cerca et al., 2006). Inactivation of"], [[306.0, 442.0, 236, 10], "antimicrobial peptides (AMPs) and complement proteins has also"], [[306.0, 452.0, 223, 10], "been observed in S. epidermidis bio\ufb01lms (Kristian et al., 2008)."], [[306.0, 464.0, 227, 10], "Moreover, bio\ufb01lm-forming S. epidermidis strains were found to"], [[306.0, 476.0, 212, 10], "impair macrophage cell activation (Schommer et al., 2011)."], [[306.0, 487.0, 230, 10], "Another issue related with bio\ufb01lms is the fact that cells adopting"], [[306.0, 499.0, 252, 10], "this mode of growth exhibit a decreased metabolic rate, which leads to"], [[306.0, 510.0, 242, 10], "lower ef\ufb01ciency of antibiotics whose action is dependent on actively"], [[306.0, 521.0, 240, 10], "growing cells (Cerca et al., 2005). Moreover, low pro-in\ufb02ammatory"], [[306.0, 533.0, 234, 10], "properties have been attributed to dormant S. epidermidis bio\ufb01lm"], [[306.0, 545.0, 87, 10], "cells (Cerca et al., 2011)."], [[306.0, 580.0, 223, 14], "IRON AND ITS BIOLOGICAL IMPORTANCE"], [[306.0, 602.0, 226, 10], "Considering that a large proportion of nosocomial infections is"], [[306.0, 613.0, 237, 10], "associated with bio\ufb01lm formation and that S. epidermidis relies on"], [[306.0, 625.0, 244, 10], "iron acquisition to survive in the host environment, it is noteworthy"], [[306.0, 637.0, 222, 10], "to explore the link between these two bacterial processes. Iron"], [[306.0, 648.0, 230, 10], "belongs to the subfamily of transition elements and is one of the"], [[306.0, 660.0, 233, 10], "most abundant metals on Earth (Frey and Reed, 2012). It is a key"], [[306.0, 671.0, 229, 10], "nutrient for almost all living organisms, including bacteria, with"], [[306.0, 683.0, 236, 10], "very few exceptions (Archibald, 1983; Troxell et al., 2012), since it"], [[306.0, 694.0, 226, 10], "participates in essential biochemical processes, such as electron"], [[306.0, 706.0, 230, 10], "transfer and catalysis (Hudson et al., 2005). In nature, most iron"], [[45.0, 743.0, 171, 7], "Frontiers in Cellular and Infection Microbiology | www.frontiersin.org"], [[295.0, 743.0, 3, 7], "2"], [[408.0, 743.0, 115, 7], "November 2021 | Volume 11 | Article 798563"]], [779, 595]], [3, [[[45.0, 30.0, 32, 7], "Oliveira et al."], [[399.0, 30.0, 129, 7], "Interplay Between S. epidermidis Bio\ufb01lms and Iron"], [[45.0, 60.0, 227, 13], "exists under the form of two oxidative states: ferrous (Fe2+) and"], [[45.0, 72.0, 227, 14], "ferric (Fe3+) iron. Under aqueous, aerobic environments, Fe2+ is"], [[45.0, 83.0, 232, 13], "spontaneously oxidized to Fe3+, leading to the formation of ferric"], [[45.0, 97.0, 244, 10], "hydroxide (Morgan and Lahav, 2007). Additionally, the solubility of"], [[45.0, 108.0, 237, 10], "ferric hydroxide under neutral pH conditions usually found in the"], [[45.0, 120.0, 237, 10], "human body is extremely low (Schwertmann, 1991). To overcome"], [[45.0, 131.0, 236, 10], "this low solubility issue, superior organisms produce proteins (e.g."], [[45.0, 141.0, 233, 14], "transferrin and ferritin) that are able to bind Fe3+ and maintain it"], [[45.0, 154.0, 226, 10], "stable while making it simultaneously available for biochemical"], [[45.0, 166.0, 87, 10], "processes (Brock, 1989)."], [[57.0, 177.0, 227, 10], "Of note, the adult human body contains approximately 3-5 g of"], [[45.0, 189.0, 234, 10], "iron (Zhang and Enns, 2009). Even though this represents a large"], [[45.0, 200.0, 235, 10], "quantity, the levels of free ferric ion available in the body are kept"], [[45.0, 210.0, 218, 14], "to a minimum (~10-24 M) (Raymond et al., 2003; Waldvogel-"], [[45.0, 223.0, 236, 10], "Abramowski et al., 2014). Therefore, most of iron is complexed as"], [[45.0, 233.0, 236, 14], "Fe2+ in several proteins, such as metalloproteins. In these proteins,"], [[45.0, 246.0, 229, 10], "iron is mostly found in the form of heme prosthetic groups (Liu"], [[45.0, 258.0, 236, 10], "et al., 2014). Hemoglobin, a well-known metalloprotein present in"], [[45.0, 269.0, 218, 10], "erythroid precursors and mature erythrocytes, represents the"], [[45.0, 280.0, 225, 12], "major iron reservoir in humans (\u223c65%). The remaining iron is"], [[45.0, 292.0, 233, 10], "stored in hepatocytes, bound to ferritin, and within macrophages"], [[45.0, 304.0, 211, 10], "(Meynard et al., 2014). A small proportion can be found in"], [[45.0, 315.0, 212, 10], "muscles within myoglobin, or as part of other cellular iron-"], [[45.0, 327.0, 231, 10], "containing proteins (Soares and Hamza, 2016). Another fraction"], [[45.0, 338.0, 214, 10], "of the iron is present in the so-called labile iron pool, which"], [[45.0, 348.0, 233, 14], "consists of redox-active iron ions (both Fe2+ and Fe3+) bound to a"], [[45.0, 360.0, 225, 10], "variety of low af\ufb01nity ligands (Kakhlon and Cabantchik, 2002)."], [[45.0, 381.0, 178, 14], "Bacterial Iron Acquisition Systems"], [[45.0, 395.0, 215, 10], "During infection, S. epidermidis faces very harsh conditions,"], [[45.0, 407.0, 215, 10], "particularly iron restriction, once it reaches the bloodstream"], [[45.0, 418.0, 211, 10], "(Cassat and Skaar, 2013). The tiny amount of iron residing"], [[45.0, 429.0, 215, 10], "extracellularly is mostly bound by high af\ufb01nity iron-binding"], [[45.0, 441.0, 232, 10], "proteins. This ensures that the concentration of free iron in body"], [[45.0, 451.0, 234, 14], "\ufb02uids and tissues can be as low as 10-24 M (Raymond et al., 2003)."], [[45.0, 464.0, 237, 10], "This is an extremely low level to support bacterial proliferation, as"], [[45.0, 476.0, 200, 10], "microorganisms typically require iron concentrations of"], [[45.0, 485.0, 227, 14], "approximately 10-6 M for growth (Miethke, 2013). Surprisingly,"], [[45.0, 499.0, 244, 10], "there is a lack of comprehensive studies available to date on the iron"], [[45.0, 510.0, 228, 10], "acquisition mechanisms in S. epidermidis, despite being a major"], [[45.0, 522.0, 237, 10], "source of bloodstream infections (Kleinschmidt et al., 2015). With"], [[45.0, 533.0, 228, 10], "very few exceptions (Archibald, 1983; Troxell et al., 2012), most"], [[45.0, 545.0, 220, 10], "pathogens rely on their ability to scavenge several biologically"], [[45.0, 556.0, 224, 10], "essential metals, including iron, for their survival, both in vitro"], [[45.0, 568.0, 232, 10], "and in vivo (Takase et al., 2000; Raymond et al., 2003; Dale et al.,"], [[45.0, 579.0, 244, 10], "2004; Beasley et al., 2009). ATP-binding cassette (ABC) transporters"], [[45.0, 591.0, 227, 10], "are among the most common bacterial iron acquisition systems"], [[45.0, 602.0, 247, 10], "(Cartron et al., 2006), which allow the uptake of iron bound either to"], [[45.0, 614.0, 223, 10], "host-derived proteins (e.g., transferrin) (Taylor and Heinrichs,"], [[45.0, 625.0, 215, 10], "2002) or bacterial-derived siderophores (Beasley et al., 2009;"], [[45.0, 637.0, 198, 10], "Brillet et al., 2012) and hemophores (Rossi et al., 2001)."], [[57.0, 648.0, 219, 10], "Siderophore-mediated iron uptake is a widely spread strategy"], [[45.0, 660.0, 234, 10], "among bacteria to survive in iron-restricted environments. While"], [[45.0, 671.0, 243, 10], "no siderophore has been described in S. epidermidis so far, there are"], [[45.0, 682.0, 235, 10], "\ufb01ndings suggesting that this species is able to produce at least one"], [[45.0, 694.0, 200, 10], "siderophore (Oliveira et al., 2017; Oliveira et al., 2021b)."], [[45.0, 706.0, 234, 10], "Siderophores are a class of small (usually less than 1 kDa), potent"], [[306.0, 60.0, 241, 14], "iron-chelating organic molecules with high af\ufb01nity for Fe3+ (Wilson"], [[306.0, 74.0, 236, 10], "et al., 2016). Siderophores generally form hexadentate, octahedral,"], [[306.0, 85.0, 223, 10], "complexes with ferric ions in a 1:1 ratio of siderophore to iron"], [[306.0, 97.0, 206, 10], "(Hider and Kong, 2010). These molecules are synthesized"], [[306.0, 108.0, 219, 10], "intracellularly and secreted into the environment as iron-free"], [[306.0, 118.0, 217, 13], "compounds (Hider and Kong, 2010). Once Fe3+-siderophore"], [[306.0, 131.0, 220, 10], "complexes are formed, their transport across the bacterial cell"], [[306.0, 143.0, 216, 10], "membrane to the cytoplasm takes place through a myriad of"], [[306.0, 154.0, 231, 10], "uptake systems, particularly ABC transporters (Chu et al., 2010)."], [[306.0, 165.0, 241, 10], "The subsequent release of iron from high af\ufb01nity siderophores may"], [[306.0, 177.0, 215, 10], "follow two different mechanisms: (i) enzymatic reduction of"], [[306.0, 187.0, 220, 14], "siderophore-bound Fe3+ to Fe2+ (Matzanke et al., 2004; Ganne"], [[306.0, 200.0, 232, 10], "et al., 2017) or (ii) enzyme-catalyzed siderophore hydrolysis (Lin"], [[306.0, 212.0, 231, 10], "et al., 2005). By the time bacterial iron requirements are met, the"], [[306.0, 223.0, 204, 10], "transcription of genes encoding iron transport systems is"], [[306.0, 235.0, 224, 10], "downregulated through the action of a repressor protein called"], [[306.0, 246.0, 205, 10], "Fur (Ferric uptake regulator) (Troxell and Hassan, 2013)."], [[306.0, 267.0, 201, 14], "Regulation of Iron Acquisition Systems"], [[306.0, 280.0, 236, 10], "The expression of different bacterial virulence factors, particularly"], [[306.0, 292.0, 233, 10], "those associated with iron acquisition, is triggered by a decreased"], [[306.0, 303.0, 219, 10], "intracellular iron content (Porcheron and Dozois, 2015). The"], [[306.0, 315.0, 224, 10], "regulatory protein Fur is key in a conserved mechanism across"], [[306.0, 326.0, 237, 10], "bacteria responsible for the regulation of transcriptional responses"], [[306.0, 338.0, 235, 10], "to iron deprivation, and is now recognized as the canonical global"], [[306.0, 349.0, 242, 10], "iron-responsive regulator in bacteria (Troxell and Hassan, 2013). In"], [[306.0, 361.0, 223, 10], "general, when the intracellular iron content surpasses the level"], [[306.0, 372.0, 223, 10], "required for proper cellular function, there is an association of"], [[306.0, 382.0, 230, 14], "one Fe2+ ion with two Fur monomers. In its dimeric form, Fur is"], [[306.0, 395.0, 225, 10], "able to bind a conserved 19-bp DNA motif within the operator"], [[306.0, 407.0, 231, 10], "region of target genes, designated as Fur box, which blocks RNA"], [[306.0, 418.0, 241, 10], "polymerase and ultimately leads to repression of gene transcription"], [[306.0, 430.0, 245, 10], "(Fillat, 2014). Once the intracellular iron levels become depleted, the"], [[306.0, 439.0, 219, 14], "Fe2+ ion dissociates from the Fur dimer, the Fur box becomes"], [[306.0, 453.0, 229, 10], "unoccupied, and transcription of target genes is resumed (Fillat,"], [[306.0, 464.0, 243, 10], "2014). Current knowledge about the involvement of iron and Fur as"], [[306.0, 476.0, 241, 10], "transcription regulators in S. epidermidis is limited but in S. aureus,"], [[306.0, 487.0, 242, 10], "Fur has been shown to regulate the transcription of iron acquisition"], [[306.0, 499.0, 244, 10], "(Hazmanian et al., 2003; Torres et al., 2006; Beasley et al., 2009) and"], [[306.0, 510.0, 209, 10], "other virulence-related genes (Torres et al., 2010), and was"], [[306.0, 521.0, 194, 10], "implicated in bio\ufb01lm formation (Johnson et al., 2005)."], [[306.0, 555.0, 176, 14], "INTERPLAY BETWEEN IRON AND"], [[306.0, 569.0, 218, 14], "BIOFILM FORMATION IN S. EPIDERMIDIS"], [[306.0, 590.0, 221, 10], "As part of the normal micro\ufb02ora of human skin and mucosae"], [[306.0, 602.0, 236, 10], "(Grice et al., 2009), S. epidermidis, and to a lesser extent S. aureus,"], [[306.0, 613.0, 231, 10], "are frequent sources of bio\ufb01lm infections associated with the use"], [[306.0, 625.0, 225, 10], "of indwelling medical devices (e.g., catheter systems, prosthetic"], [[306.0, 637.0, 203, 10], "joints, and a range of other polymer and metal implants)"], [[306.0, 648.0, 207, 10], "(McCann et al., 2008; Hogan et al., 2015; Lourtet-Hasco\u00ebt"], [[306.0, 660.0, 215, 10], "et al., 2016) and are also implicated in more serious medical"], [[306.0, 671.0, 221, 10], "conditions (e.g., sepsis) (Kleinschmidt et al., 2015; Tong et al.,"], [[306.0, 682.0, 225, 10], "2015). Staphylococcal bio\ufb01lms have been the focus of intensive"], [[306.0, 694.0, 226, 10], "research, and the role of iron in this process has been explored."], [[306.0, 705.0, 229, 10], "However, the regulatory role of iron in S. epidermidis bio\ufb01lms is"], [[45.0, 743.0, 171, 7], "Frontiers in Cellular and Infection Microbiology | www.frontiersin.org"], [[295.0, 743.0, 3, 7], "3"], [[408.0, 743.0, 115, 7], "November 2021 | Volume 11 | Article 798563"]], [779, 595]], [4, [[[45.0, 30.0, 32, 7], "Oliveira et al."], [[399.0, 30.0, 129, 7], "Interplay Between S. epidermidis Bio\ufb01lms and Iron"], [[45.0, 62.0, 212, 10], "not well understood, mostly due to the considerable lack of"], [[45.0, 73.0, 218, 10], "studies. The \ufb01rst study dates back to early 90s (Deighton and"], [[45.0, 85.0, 230, 10], "Borland, 1993) and demonstrated that most strains displayed an"], [[45.0, 96.0, 215, 10], "enhanced bio\ufb01lm formation ability under conditions of iron"], [[45.0, 108.0, 224, 10], "limitation, although this phenotype was strain-dependent and,"], [[45.0, 120.0, 240, 10], "in some cases, only becomes apparent after a prolonged incubation"], [[45.0, 130.0, 238, 10], "period (48 hours). During the \ufb01rst 24 hours, this stimulatory effect"], [[45.0, 142.0, 236, 10], "was only evident for strains classi\ufb01ed as weak or moderate bio\ufb01lm"], [[45.0, 154.0, 233, 10], "producers, while iron limitation produced an inhibitory effect for"], [[45.0, 165.0, 218, 10], "strong bio\ufb01lm producers. A renewed interest in this \ufb01eld was"], [[45.0, 176.0, 222, 10], "raised by the astonishing \ufb01nding that catecholamine inotropic"], [[45.0, 189.0, 231, 10], "drugs, which are frequently administered in intensive-care units,"], [[45.0, 199.0, 236, 10], "signi\ufb01cantly promote bio\ufb01lm formation by S. epidermidis through"], [[45.0, 212.0, 238, 10], "sequestration of iron from transferrin (Neal et al., 2001; Lyte et al.,"], [[45.0, 222.0, 212, 10], "2003). The importance of iron for S. epidermidis bio\ufb01lms is"], [[45.0, 234.0, 199, 10], "underscored by the fact that bio\ufb01lm cells upregulate the"], [[45.0, 246.0, 229, 10], "transcription of genes involved in iron acquisition upon contact"], [[45.0, 257.0, 229, 11], "with human blood (Franc\u0327a et al., 2014). In another study, it was"], [[45.0, 269.0, 224, 10], "demonstrated that the ability of different strains, including the"], [[45.0, 281.0, 222, 10], "reference strain S. epidermidis ATCC 35984 (RP62A), to form"], [[45.0, 291.0, 230, 10], "bio\ufb01lms is strongly inhibited under iron-limiting conditions due"], [[45.0, 304.0, 234, 10], "to a delayed growth rate, reduced cell viability and impaired PIA/"], [[45.0, 315.0, 219, 10], "PNAG production (Oliveira et al., 2017). Iron excess (1 mM)"], [[45.0, 326.0, 229, 10], "produces a mildly detrimental effect in bio\ufb01lm formation that is"], [[45.0, 338.0, 226, 10], "not related with PIA/PNAG (Oliveira et al., 2017). Siderophore"], [[45.0, 350.0, 232, 10], "biosynthesis or iron/siderophore transport systems, although not"], [[45.0, 361.0, 220, 10], "fundamental for planktonic growth under iron starvation, are"], [[45.0, 372.0, 231, 10], "absolutely required for bio\ufb01lm formation under these conditions"], [[45.0, 384.0, 82, 10], "(Oliveira et al., 2021b)."], [[45.0, 424.0, 198, 14], "SIDEROPHORES AND THEIR ROLE IN"], [[45.0, 438.0, 151, 14], "BACTERIAL PATHOGENESIS"], [[45.0, 460.0, 231, 10], "The perception of bacterial iron acquisition systems, particularly"], [[45.0, 472.0, 233, 10], "siderophores, as virulence factors is derived from the observation"], [[45.0, 483.0, 222, 10], "that their inactivation results in a measurable loss of virulence"], [[45.0, 495.0, 220, 10], "(Meyer et al., 1996; Rabsch et al., 2003; Monta\u00f1ez et al., 2005;"], [[45.0, 506.0, 232, 10], "Beasley et al., 2011; Reddy et al., 2013; Runci et al., 2019). One of"], [[45.0, 518.0, 238, 10], "the host mechanisms to counteract bacterial iron acquisition is the"], [[45.0, 529.0, 216, 10], "secretion of lipocalin 2 (Lcn2) by cells of the innate immune"], [[45.0, 541.0, 206, 10], "system, blocking the action of some siderophores, such as"], [[45.0, 552.0, 211, 10], "enterobactin (Flo et al., 2004). Bacteria overcome this issue"], [[45.0, 564.0, 208, 10], "through the production of diverse, functionally redundant"], [[45.0, 575.0, 230, 10], "siderophores, some of them being resistant to the action of Lcn2"], [[45.0, 586.0, 234, 10], "(also referred to as \u201cstealth siderophores\u201d) (Fischbach et al., 2006;"], [[45.0, 598.0, 216, 10], "Bachman et al., 2011). This, together with the implication of"], [[45.0, 610.0, 225, 10], "siderophores in roles other than iron sequestration, such as the"], [[45.0, 621.0, 219, 10], "modulation of host cellular pathways (Holden and Bachman,"], [[45.0, 633.0, 216, 10], "2015), seems to provide an adaptive advantage over the host"], [[45.0, 644.0, 215, 10], "immune response and contributes to bacterial pathogenesis."], [[45.0, 656.0, 211, 10], "Assigning this kind of roles across different siderophores is"], [[45.0, 667.0, 225, 10], "dif\ufb01cult not only due to their structural and chemical diversity,"], [[45.0, 679.0, 234, 10], "but also because their biosynthesis may follow different pathways"], [[45.0, 690.0, 212, 10], "even in the most closely related species. Staphylococci are a"], [[45.0, 702.0, 199, 10], "paradigmatic example: S. aureus produces two different"], [[306.0, 62.0, 214, 10], "siderophores (staphyloferrins A and B) (Beasley et al., 2009;"], [[306.0, 74.0, 226, 10], "Cotton et al., 2009), S. epidermidis synthesizes staphyloferrin A"], [[306.0, 85.0, 195, 10], "only (Oliveira et al., 2021b), and S. lugdunensis hijacks"], [[306.0, 97.0, 214, 10], "siderophores from other staphylococci instead of producing"], [[306.0, 107.0, 207, 10], "them (Brozyna et al., 2014) (Figure 1A). Another striking"], [[306.0, 120.0, 233, 10], "difference regarding iron acquisition among staphylococci is that"], [[306.0, 131.0, 223, 10], "S. aureus and S. lugdunensis have a system dedicated to heme-"], [[306.0, 143.0, 234, 10], "bound iron acquisition, called iron-regulated surface determinant"], [[306.0, 154.0, 238, 10], "(Isd) (Torres et al., 2006; Heilbronner et al., 2011), which is absent"], [[306.0, 166.0, 218, 10], "in S. epidermidis. Therefore, the absence of the Isd system, in"], [[306.0, 177.0, 205, 10], "combination with the production of a single siderophore,"], [[306.0, 189.0, 200, 10], "underscores the relevance of siderophore-mediated iron"], [[306.0, 200.0, 103, 10], "acquisition in S. epidermidis."], [[318.0, 212.0, 191, 10], "The contribution of staphyloferrins in staphylococcal"], [[306.0, 223.0, 219, 10], "pathogenicity has been evidenced by the reduced virulence of"], [[306.0, 234.0, 216, 10], "siderophore-de\ufb01cient S. aureus in different murine infection"], [[306.0, 246.0, 221, 10], "models (Dale et al., 2004; Nakaminami et al., 2017). This may"], [[306.0, 258.0, 232, 10], "be partly explained by the protective effect of staphyloferrin A to"], [[306.0, 269.0, 228, 10], "cells residing in host phagocytic cells. Deletion of S. epidermidis"], [[306.0, 281.0, 215, 10], "sfaABCD, which mediates siderophore biosynthesis, leads to"], [[306.0, 291.0, 214, 10], "compromised \ufb01tness in the macrophage intracellular milieu"], [[306.0, 304.0, 227, 10], "and increased susceptibility to reactive oxygen species (Oliveira"], [[306.0, 314.0, 93, 10], "et al., 2021b) (Figure 1B)."], [[306.0, 353.0, 156, 14], "EXPLOITING THE BACTERIAL"], [[306.0, 367.0, 153, 14], "DEPENDENCE ON IRON FOR"], [[306.0, 381.0, 141, 14], "THERAPEUTIC PURPOSES"], [[306.0, 403.0, 242, 10], "The importance of iron and siderophores for bio\ufb01lm formation and"], [[306.0, 415.0, 206, 10], "virulence across different nosocomial pathogens offers an"], [[306.0, 426.0, 212, 10], "opportunity for the development of new strategies to tackle"], [[306.0, 437.0, 213, 10], "bio\ufb01lm-associated infections. Bacterial iron uptake systems,"], [[306.0, 449.0, 217, 10], "particularly siderophore and heme transport systems, can be"], [[306.0, 460.0, 229, 10], "exploited as gateways for the delivery of so-called \u201ctrojan horse\u201d"], [[306.0, 472.0, 238, 10], "compounds into the bacterial cytoplasm. One possible approach is"], [[306.0, 484.0, 216, 10], "to use the heme synthetic analog gallium-protoporphyrin IX"], [[306.0, 495.0, 223, 10], "(GaPP) to facilitate the delivery of gallium into bio\ufb01lms. GaPP"], [[306.0, 506.0, 240, 10], "has demonstrated remarkable antibio\ufb01lm activity against S. aureus,"], [[306.0, 518.0, 238, 10], "which is enhanced in combination with other compounds, such as"], [[306.0, 530.0, 236, 10], "gallium nitrate, iron chelating agents and conventional antibiotics"], [[306.0, 541.0, 243, 10], "(Chang et al., 2016; Richter et al., 2016; Richter et al., 2017a; Richter"], [[306.0, 553.0, 251, 10], "et al., 2017b; Choi et al., 2019a; Choi et al., 2019b). The use of GaPP is"], [[306.0, 564.0, 243, 10], "encouraged by the safety it demonstrated across cytotoxicity studies"], [[306.0, 576.0, 243, 10], "in different human cell lines, primary human cells and mice (Chang"], [[306.0, 587.0, 232, 10], "et al., 2016), although further studies are required on this matter."], [[306.0, 599.0, 235, 10], "Nevertheless, care must be taken when selecting carrier molecules"], [[306.0, 610.0, 232, 10], "for the bacterial uptake of gallium, which should be based on the"], [[306.0, 621.0, 227, 10], "target species. For instance, despite the ef\ufb01cacy of GaPP against"], [[306.0, 633.0, 201, 10], "staphylococci, complexation of gallium with their native"], [[306.0, 645.0, 208, 10], "siderophore staphyloferrin A results in poor antimicrobial"], [[306.0, 656.0, 217, 10], "activity, raising some concerns about the suitability of native"], [[306.0, 668.0, 221, 10], "siderophores as carriers of gallium-based compounds (Kelson"], [[306.0, 679.0, 237, 10], "et al., 2013). The \u201ctrojan horse\u201d strategy may also be employed for"], [[306.0, 691.0, 242, 10], "improved delivery of conventional antibiotics to pathogens through"], [[306.0, 702.0, 228, 10], "their conjugation with siderophores. Surprisingly, while there is"], [[45.0, 743.0, 171, 7], "Frontiers in Cellular and Infection Microbiology | www.frontiersin.org"], [[295.0, 743.0, 3, 7], "4"], [[408.0, 743.0, 115, 7], "November 2021 | Volume 11 | Article 798563"]], [779, 595]], [5, [[[45.0, 30.0, 32, 7], "Oliveira et al."], [[122.0, 81.0, 5, 9], "A"], [[399.0, 30.0, 129, 7], "Interplay Between S. epidermidis Bio\ufb01lms and Iron"], [[357.0, 81.0, 5, 9], "B"], [[50.0, 292.0, 427, 7], "FIGURE 1 | Siderophore-mediated iron acquisition in staphylococci. (A) While S. aureus produces two different siderophores (staphyloferrin A, SA, and staphyloferrin B,"], [[50.0, 302.0, 423, 7], "SB), S. epidermidis synthesizes SA only, and S. lugdunensis hijacks SA and SB from these two staphylococci species instead of producing them. After being secreted"], [[50.0, 311.0, 427, 7], "into the extracellular medium, SA and SB bind to extracellular iron (Fe) and make their way back to the cell as siderophore-iron complexes (SA-Fe and SB-Fe), providing"], [[50.0, 321.0, 408, 7], "the iron levels required for several bacterial processes, including bio\ufb01lm formation. (B) In S. epidermidis, SA-mediated iron acquisition has recently been found to"], [[50.0, 330.0, 388, 7], "contribute to bacterial survival in human macrophages, by withstanding the action of certain reactive oxygen species, such as hydrogen peroxide (H2O2)."], [[45.0, 360.0, 238, 10], "evidence about the promising antibacterial activity of this group of"], [[45.0, 371.0, 234, 10], "compounds against Gram-positive and Gram-negative pathogens"], [[45.0, 383.0, 243, 10], "(Ji et al., 2012; Wencewicz et al., 2013; Ito et al., 2016; Ito-Horiyama"], [[45.0, 394.0, 213, 10], "et al., 2016), its ef\ufb01cacy against bio\ufb01lms, in which antibiotic"], [[45.0, 406.0, 226, 10], "penetration is particularly dampened, remains unknown and is"], [[45.0, 417.0, 99, 10], "worth further investigation."], [[57.0, 429.0, 225, 10], "Iron acquisition-related molecules are also regarded as suitable"], [[45.0, 440.0, 242, 10], "target candidates for vaccine development since they display a good"], [[45.0, 452.0, 231, 10], "degree of conservation and their expression is readily induced as"], [[45.0, 463.0, 233, 10], "soon as pathogens invade the host and face nutritional immunity"], [[45.0, 474.0, 215, 10], "(Sheldon and Heinrichs, 2012). The Syntiron/Sano\ufb01 Pasteur"], [[45.0, 486.0, 219, 10], "consortium recently started preclinical trials on a multivalent"], [[45.0, 498.0, 203, 10], "vaccine based on four iron-regulated lipoproteins for the"], [[45.0, 509.0, 225, 10], "prevention of S. aureus skin and soft tissue infection (Syntiron,"], [[45.0, 520.0, 233, 10], "Sano\ufb01 Pasteur, 2018), although no detailed information has been"], [[45.0, 532.0, 86, 10], "made publicly available."], [[45.0, 567.0, 194, 14], "CONCLUSIONS AND PERSPECTIVES"], [[45.0, 589.0, 236, 10], "S. epidermidis bio\ufb01lm-associated infections are an increasing issue"], [[45.0, 601.0, 203, 10], "worldwide and have posed huge challenges to healthcare"], [[45.0, 613.0, 198, 10], "professionals. In the years to come, the global spread of"], [[45.0, 624.0, 218, 10], "multidrug-resistant lineages (Lee et al., 2018) may render the"], [[45.0, 635.0, 200, 10], "treatment of S. epidermidis bio\ufb01lm-associated infections"], [[45.0, 646.0, 226, 10], "extremely dif\ufb01cult. Given this likely scenario, there is an urgent"], [[45.0, 659.0, 239, 10], "need to identify alternative bacterial targets for the development of"], [[45.0, 670.0, 235, 10], "novel anti-infective strategies. During the last years, we have been"], [[45.0, 682.0, 206, 10], "witnessing a renewed interest in bacterial iron acquisition"], [[45.0, 692.0, 235, 10], "mechanisms, mostly due to very promising \ufb01ndings underscoring"], [[45.0, 704.0, 238, 10], "the complex regulatory role of iron in bio\ufb01lm formation, as well as"], [[306.0, 360.0, 243, 10], "the major role of siderophores in the virulence of several pathogens,"], [[306.0, 371.0, 236, 10], "including S. epidermidis. Consequently, this has put a spotlight on"], [[306.0, 383.0, 236, 10], "iron acquisition-related processes and brought a new hope for the"], [[306.0, 394.0, 223, 10], "development of a much-needed new generation of therapeutic"], [[306.0, 406.0, 201, 10], "strategies against life-threatening nosocomial infections."], [[306.0, 417.0, 224, 10], "Nevertheless, there is still a long road ahead, as we still need to"], [[306.0, 429.0, 241, 10], "achieve a deeper understanding of the different biological roles that"], [[306.0, 440.0, 242, 10], "siderophores may assume in the pathogenicity of bio\ufb01lm-associated"], [[306.0, 452.0, 198, 10], "infections and, most importantly, of the whole range of"], [[306.0, 463.0, 196, 10], "consequences of inhibiting iron acquisition in bacteria."], [[306.0, 498.0, 176, 14], "DATA AVAILABILITY STATEMENT"], [[306.0, 521.0, 232, 10], "The original contributions presented in the study are included in"], [[306.0, 532.0, 214, 10], "the article/supplementary material. Further inquiries can be"], [[306.0, 544.0, 134, 10], "directed to the corresponding author."], [[306.0, 579.0, 142, 14], "AUTHOR CONTRIBUTIONS"], [[306.0, 601.0, 242, 10], "NC and FO drafted the \ufb01rst version of the manuscript. HR and MV"], [[306.0, 612.0, 240, 10], "reviewed and edited the \ufb01rst version of the manuscript. All authors"], [[306.0, 624.0, 223, 10], "contributed to the article and approved the submitted version."], [[306.0, 659.0, 50, 13], "FUNDING"], [[306.0, 680.0, 232, 11], "FO is supported by the Fundac\u0327\u00e3o para a Cien\u0302 cia e a Tecnologia"], [[306.0, 693.0, 245, 10], "research project with reference PTDC/BIA-MOL/29553/2017, under"], [[306.0, 704.0, 226, 10], "the scope of COMPETE2020 (POCI-01-0145-FEDER-029553)."], [[45.0, 743.0, 171, 7], "Frontiers in Cellular and Infection Microbiology | www.frontiersin.org"], [[295.0, 743.0, 3, 7], "5"], [[408.0, 743.0, 115, 7], "November 2021 | Volume 11 | Article 798563"]], [779, 595]], [6, [[[45.0, 30.0, 32, 7], "Oliveira et al."], [[399.0, 30.0, 129, 7], "Interplay Between S. epidermidis Bio\ufb01lms and Iron"], [[45.0, 62.0, 74, 13], "REFERENCES"], [[45.0, 81.0, 209, 14], "A\u0301 guila-Arcos, S., A\u0301 lvarez-Rodr\u0131\u0301guez, I., Garaiyurrebaso, O., Garbisu, C.,"], [[55.0, 92.0, 177, 8], "Grohmann, E., and Alkorta, I. (2017). Bio\ufb01lm-Forming Clinical"], [[55.0, 102.0, 185, 8], "Staphylococcus Isolates Harbor Horizontal Transfer and Antibiotic"], [[55.0, 112.0, 208, 8], "Resistance Genes. Front. Microbiol. 8, 2018. doi: 10.3389/fmicb.2017.02018"], [[45.0, 121.0, 229, 8], "Allegranzi, B., Nejad, S. B., Combescure, C., Graafmans, W., Attar, H., Donaldson,"], [[55.0, 131.0, 202, 8], "L, et al. (2011). Report on the Burden of Endemic Health Care-Associated"], [[55.0, 140.0, 213, 8], "Infection Worldwide (Geneva 27, Switzerland:WHO Library Cataloguing-in-"], [[55.0, 150.0, 51, 8], "Publication Data)."], [[45.0, 159.0, 222, 8], "Andrews, S. C., Robinson, A. K., and Rodr\u0131g\u0301 uez-Qui\u00f1ones, F. (2003). Bacterial"], [[55.0, 168.0, 205, 8], "Iron Homeostasis. FEMS Microbiol. Rev. 27 (2\u20133), 215\u2013237. doi: 10.1016/"], [[55.0, 179.0, 68, 8], "S0168-6445(03)00055-X"], [[45.0, 188.0, 224, 8], "Archibald, F. (1983). Lactobacillus plantarum, an Organism Not Requiring Iron."], [[55.0, 197.0, 215, 8], "FEMS Microbiol. Lett. 19 (1), 29\u201332. doi: 10.1111/j.1574-6968.1983.tb00504.x"], [[45.0, 206.0, 230, 8], "Bachman, M. A., Oyler, J. E., Burns, S. H., Caza, M., Le\u0301pine, F., Dozois, C. M, et al."], [[55.0, 217.0, 204, 8], "(2011). Klebsiella pneumoniae Yersiniabactin Promotes Respiratory Tract"], [[55.0, 225.0, 205, 8], "Infection Through Evasion of Lipocalin 2. Infect. Immun 79 (8), 3309\u201316."], [[55.0, 235.0, 73, 8], "doi: 10.1128/IAI.05114-11"], [[45.0, 245.0, 219, 8], "Beasley, F. C., Marolda, C. L., Cheung, J., Buac, S., and Heinrichs, D. E. (2011)."], [[55.0, 254.0, 211, 8], "Staphylococcus aureus Transporters Hts, Sir, and Sst Capture Iron Liberated"], [[55.0, 264.0, 192, 8], "From Human Transferrin by Staphyloferrin A, Staphyloferrin B, and"], [[55.0, 273.0, 212, 8], "Catecholamine Stress Hormones, Respectively, and Contribute to Virulence."], [[55.0, 282.0, 170, 8], "Infect. Immun. 79 (6), 2345\u20132355. doi: 10.1128/IAI.00117-11"], [[45.0, 292.0, 233, 8], "Beasley, F. C., Vine\u0301s, E. D., Grigg, J. C., Zheng, Q., Liu, S., Lajoie, G. A, et al. (2009)."], [[55.0, 302.0, 213, 8], "Characterization of Staphyloferrin A Biosynthetic and Transport Mutants in"], [[55.0, 311.0, 211, 8], "Staphylococcus aureus. Mol. Microbiol. 72 (4), 947\u2013963. doi: 10.1111/j.1365-"], [[55.0, 321.0, 51, 8], "2958.2009.06698.x"], [[45.0, 330.0, 227, 8], "Brandwein, M., Steinberg, D., and Meshner, S. (2016). Microbial Bio\ufb01lms and the"], [[55.0, 339.0, 219, 8], "Human Skin Microbiome. NPJ Bio\ufb01lms. Microbiom. 2, 3. doi: 10.1038/s41522-"], [[55.0, 350.0, 31, 8], "016-0004-z"], [[45.0, 359.0, 230, 8], "Brillet, K., Ruffenach, F., Adams, H., Journet, L., Gasser, V., Hoegy, F, et al. (2012)."], [[55.0, 368.0, 220, 8], "An ABC Transporter With Two Periplasmic Binding Proteins Involved in Iron"], [[55.0, 377.0, 218, 8], "Acquisition in Pseudomonas aeruginosa. ACS Chem. Biol 7 (12), 2036\u201345. doi:"], [[55.0, 387.0, 54, 8], "10.1021/cb300330v"], [[45.0, 397.0, 231, 8], "Brock, J. H. (1989). Iron-Binding Proteins. Acta Paediatri. Scand. Supplement. 361,"], [[55.0, 406.0, 112, 8], "31\u201343. doi: 10.1111/apa.1989.78.s361.31"], [[45.0, 416.0, 222, 8], "Brozyna, J. R., Sheldon, J. R., and Heinrichs, D. E. (2014). Growth Promotion of"], [[55.0, 426.0, 209, 8], "the Opportunistic Human Pathogen, Staphylococcus lugdunensis, by Heme,"], [[55.0, 435.0, 216, 8], "Hemoglobin, and Coculture With Staphylococcus aureus. MicrobiologyOpen 3"], [[55.0, 444.0, 102, 8], "(2), 182\u2013195. doi: 10.1002/mbo3.162"], [[45.0, 454.0, 219, 8], "Cartron, M. L., Maddocks, S., Gillingham, P., Craven, C. J., and Andrews, S. C."], [[55.0, 463.0, 222, 8], "(2006). Feo - Transport of Ferrous Iron Into Bacteria. BioMetals 19 (2), 143\u201357."], [[55.0, 473.0, 90, 8], "doi: 10.1007/s10534-006-0003-2"], [[45.0, 483.0, 219, 8], "Cassat, J. E., and Skaar, E. P. (2013). Iron in Infection and Immunity. Cell Host"], [[55.0, 491.0, 161, 8], "Microbe 13 (5), 509\u2013519. doi: 10.1016/j.chom.2013.04.010"], [[45.0, 499.0, 233, 14], "Cerca, F., Andrade, F., Franc\u0327a, A\u0302 ., Andrade, E. B., Ribeiro, A., Almeida, A. A, et al."], [[55.0, 510.0, 201, 8], "(2011). Staphylococcus epidermidis Bio\ufb01lms With Higher Proportions of"], [[55.0, 520.0, 202, 8], "Dormant Bacteria Induce a Lower Activation of Murine Macrophages. J."], [[55.0, 529.0, 171, 8], "Med. Microbiol. 60, 1717\u20131724. doi: 10.1099/jmm.0.031922-0"], [[45.0, 539.0, 205, 8], "Cerca, N., Jefferson, K. K., Oliveira, R., Pier, G. B., and Azeredo, J. (2006)."], [[55.0, 549.0, 214, 8], "Comparative Antibody-Mediated Phagocytosis of Staphylococcus epidermidis"], [[55.0, 558.0, 206, 8], "Cells Grown in a Bio\ufb01lm or in the Planktonic State. Infect. Immun. 74 (8),"], [[55.0, 567.0, 107, 8], "4849\u20134855. doi: 10.1128/IAI.00230-06"], [[45.0, 578.0, 214, 8], "Cerca, N., Martins, S., Cerca, F., Jefferson, K. K., Pier, G. B., Oliveira, R, et al."], [[55.0, 587.0, 208, 8], "(2005). Comparative Assessment of Antibiotic Susceptibility of Coagulase-"], [[55.0, 596.0, 212, 8], "Negative Staphylococci in Bio\ufb01lm Versus Planktonic Culture as Assessed by"], [[55.0, 606.0, 188, 8], "Bacterial Enumeration or Rapid XTT Colorimetry. J. Antimicrobial."], [[55.0, 615.0, 146, 8], "Chemother. 56 (2), 331\u2013336. doi: 10.1093/jac/dki217"], [[45.0, 625.0, 229, 8], "Chang, D., Garcia, R. A., Akers, K. S., Mende, K., Murray, C. K., Wenke, J. C, et al."], [[55.0, 634.0, 213, 8], "(2016). Activity of Gallium Meso-and Protoporphyrin Ix Against Bio\ufb01lms of"], [[55.0, 644.0, 216, 8], "Multidrug-Resistant Acinetobacter baumannii Isolates. Pharmaceuticals 9 (1),"], [[55.0, 653.0, 77, 8], "16. doi: 10.3390/ph9010016"], [[45.0, 663.0, 230, 8], "Choi, S. R., Britigan, B. E., and Narayanasamy, P. (2019a). Iron/heme Metabolism-"], [[55.0, 672.0, 204, 8], "Targeted Gallium(III) Nanoparticles are Active Against Extracellular and"], [[55.0, 682.0, 191, 8], "Intracellular Pseudomonas aeruginosa and Acinetobacter baumannii."], [[55.0, 691.0, 183, 8], "Antimicrobial. Agents Chemother 63 (4), e02643\u201318. doi: 10.1128/"], [[55.0, 701.0, 42, 8], "AAC.02643-18"], [[306.0, 62.0, 214, 8], "Choi, S. R., Britigan, B. E., and Narayanasamy, P. (2019b). Dual Inhibition of"], [[316.0, 72.0, 212, 8], "Klebsiella pneumoniae and Pseudomonas aeruginosa Iron Metabolism Using"], [[316.0, 80.0, 219, 8], "Gallium Porphyrin and Gallium Nitrate. ACS Infect. Dis 5 (9), 1559\u20131569. doi:"], [[316.0, 91.0, 79, 8], "10.1021/acsinfecdis.9b00100"], [[306.0, 100.0, 223, 8], "Christner, M., Franke, G. C., Schommer, N. N., Wendt, U., Wegert, K., Pehle, P,"], [[316.0, 110.0, 219, 8], "et al. (2010). The Giant Extracellular Matrix-Binding Protein of Staphylococcus"], [[316.0, 118.0, 213, 8], "epidermidis Mediates Bio\ufb01lm Accumulation and Attachment to Fibronectin."], [[316.0, 128.0, 198, 8], "Mol. Microbiol. 75 (1), 187\u2013207. doi: 10.1111/j.1365-2958.2009.06981.x"], [[306.0, 138.0, 212, 8], "Chu, B. C., Garcia-Herrero, A., Johanson, T. H., Krewulak, K. D., Lau, C. K.,"], [[316.0, 148.0, 214, 8], "Peacock, R. S, et al. (2010). Siderophore Uptake in Bacteria and the Battle for"], [[316.0, 156.0, 222, 8], "Iron With the Host; a Bird\u2019s Eye View. BioMetals 23 (4), 601\u2013611. doi: 10.1007/"], [[316.0, 167.0, 54, 8], "s10534-010-9361-x"], [[306.0, 175.0, 226, 8], "Cotton, J. L., Tao, J., and Balibar, C. J. (2009). Identi\ufb01cation and Characterization"], [[316.0, 186.0, 197, 8], "of the Staphylococcus aureus Gene Cluster Coding for Staphyloferrin a."], [[316.0, 194.0, 155, 8], "Biochemistry 48 (5), 1025\u20131035. doi: 10.1021/bi801844c"], [[306.0, 205.0, 215, 8], "Dale, S. E., Doherty-Kirby, A., Lajoie, G., and Heinrichs, D. E. (2004). Role of"], [[316.0, 213.0, 217, 8], "Siderophore Biosynthesis in Virulence of Staphylococcus aureus: Identi\ufb01cation"], [[316.0, 224.0, 220, 8], "and Characterization of Genes Involved in Production of a Siderophore. Infect."], [[316.0, 232.0, 155, 8], "Immun. 72 (1), 29\u201337. doi: 10.1128/IAI.72.1.29-37.2004"], [[306.0, 243.0, 246, 8], "Decker, R., Burdelski, C., Zobiak, M., B\u00fcttner, H., Franke, G., Christner, M, et al. (2015)."], [[316.0, 251.0, 214, 8], "An 18 kDa Scaffold Protein Is Critical for Staphylococcus epidermidis Bio\ufb01lm"], [[316.0, 262.0, 214, 8], "Formation. PloS Pathog. 11 (3), e1004735. doi: 10.1371/journal.ppat.1004735"], [[306.0, 271.0, 202, 8], "Deighton, M., and Borland, R. (1993). Regulation of Slime Production in"], [[316.0, 281.0, 196, 8], "Staphylococcus epidermidis By Iron Limitation. Infect. Immun. 61 (10),"], [[316.0, 289.0, 139, 8], "4473\u20134479. doi: 10.1128/iai.61.10.4473-4479.1993"], [[306.0, 299.0, 218, 8], "Dengler Haunreiter, V., Boumasmoud, M., H\u00e4ffner, N., Wip\ufb02i, D., Leimer, N.,"], [[316.0, 309.0, 218, 8], "Rachm\u00fchl, C, et al. (2019). In-Host Evolution of Staphylococcus epidermidis in"], [[316.0, 319.0, 198, 8], "a Pacemaker-Associated Endocarditis Resulting in Increased Antibiotic"], [[316.0, 328.0, 204, 8], "Tolerance. Nat. Commun. 10 (1), 1149. doi: 10.1038/s41467-019-09053-9"], [[306.0, 337.0, 228, 8], "De Vos, W. M. (2015). Microbial Bio\ufb01lms and the Human Intestinal Microbiome."], [[316.0, 346.0, 187, 8], "NPJ Bio\ufb01lms. Microbiom. 1, 15005. doi: 10.1038/npjbio\ufb01lms.2015.5"], [[306.0, 356.0, 216, 8], "Donlan, R. M., and Costerton, J. W. (2002). Bio\ufb01lms: Survival Mechanisms of"], [[316.0, 365.0, 219, 8], "Clinically Relevant Microorganisms. Clin. Microbiol. Rev. 15 (2), 167\u2013193. doi:"], [[316.0, 376.0, 91, 8], "10.1128/CMR.15.2.167-193.2002"], [[306.0, 385.0, 192, 8], "European Centre for Disease Prevention and Control. (2018) Annual"], [[316.0, 395.0, 215, 8], "Epidemiological Report for 2016: Healthcare-Associated Infections in Intensive"], [[316.0, 403.0, 212, 8], "Care Units. Available at: https://ecdc.europa.eu/sites/portal/\ufb01les/documents/"], [[316.0, 414.0, 76, 8], "AER_for_2016-HAI_0.pdf."], [[306.0, 422.0, 219, 8], "Fey, P. D., and Olson, M. E. (2010). Current Concepts in Bio\ufb01lm Formation of"], [[316.0, 432.0, 208, 8], "Staphylococcus epidermidis. Future Microbiol. 5 (6), 917\u2013933. doi: 10.2217/"], [[316.0, 442.0, 28, 8], "fmb.10.56"], [[306.0, 452.0, 231, 8], "Fillat, M. F. (2014). The FUR (Ferric Uptake Regulator) Superfamily: Diversity and"], [[316.0, 460.0, 220, 8], "Versatility of Key Transcriptional Regulators. Arch. Biochem. Biophys. 546, 41\u2013"], [[316.0, 471.0, 94, 8], "52. doi: 10.1016/j.abb.2014.01.029"], [[306.0, 480.0, 223, 8], "Fischbach, M. A., Lin, H., Zhou, L., Yu, Y., Abergel, R. J., Liu, D. R, et al. (2006)."], [[316.0, 490.0, 208, 8], "The Pathogen-Associated iroA Gene Cluster Mediates Bacterial Evasion of"], [[316.0, 498.0, 205, 8], "Lipocalin 2. Proc Natl Acad Sci USA 103 (44), 16502\u201316507. doi: 10.1073/"], [[316.0, 509.0, 48, 8], "pnas.0604636103"], [[306.0, 518.0, 208, 8], "Flemming, H. C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., and"], [[316.0, 527.0, 214, 8], "Kjelleberg, S. (2016). Bio\ufb01lms: An Emergent Form of Bacterial Life. Nat. Rev."], [[316.0, 536.0, 159, 8], "Microbiol. 14 (9), 563\u2013575. doi: 10.1038/nrmicro.2016.94"], [[306.0, 547.0, 232, 8], "Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K, et al."], [[316.0, 556.0, 195, 8], "(2004). Lipocalin 2 Mediates an Innate Immune Response to Bacterial"], [[316.0, 565.0, 204, 8], "Infection by Sequestrating Iron. Nature 432 (7019), 917\u201321. doi: 10.1038/"], [[316.0, 575.0, 35, 8], "nature03104"], [[306.0, 584.0, 225, 8], "Franc\u0327a, A., Carvalhais, V., Maira-Litra\u0301n, T., Vilanova, M., Cerca, N., and Pier, G."], [[316.0, 593.0, 212, 8], "(2014). Alterations in the Staphylococcus epidermidis Bio\ufb01lm Transcriptome"], [[316.0, 603.0, 210, 8], "Following Interaction With Whole Human Blood. Pathog. Dis. 70 (3), 444\u2013"], [[316.0, 613.0, 98, 8], "448. doi: 10.1111/2049-632X.12130"], [[306.0, 623.0, 224, 8], "Frey, P. A., and Reed, G. H. (2012). The Ubiquity of Iron. ACS Chem. Biol. 7 (9),"], [[316.0, 631.0, 100, 8], "1477\u20131481. doi: 10.1021/cb300323q"], [[306.0, 642.0, 226, 8], "Ganne, G., Brillet, K., Basta, B., Roche, B., Hoegy, F., Gasser, V, et al. (2017). Iron"], [[316.0, 651.0, 221, 8], "Release From the Siderophore Pyoverdine in Pseudomonas aeruginosa Involves"], [[316.0, 660.0, 207, 8], "Three New Actors: FpvC, FpvG, and FpvH. ACS Chem. Biol. 12 (4), 1056\u2013"], [[316.0, 670.0, 111, 8], "1065. doi: 10.1021/acschembio.6b01077"], [[306.0, 680.0, 224, 8], "Grice, E. A., Kong, H. H., Conlan, S., Deming, C. B., Davis, J., Young, A. C, et al."], [[316.0, 689.0, 186, 8], "(2009). Topographical and Temporal Diversity of the Human Skin"], [[316.0, 698.0, 207, 8], "Microbiome. Science 324 (5931), 1190\u20131192. doi: 10.1126/science.1171700"], [[45.0, 743.0, 171, 7], "Frontiers in Cellular and Infection Microbiology | www.frontiersin.org"], [[295.0, 743.0, 3, 7], "6"], [[408.0, 743.0, 115, 7], "November 2021 | Volume 11 | Article 798563"]], [779, 595]], [7, [[[45.0, 30.0, 32, 7], "Oliveira et al."], [[399.0, 30.0, 129, 7], "Interplay Between S. epidermidis Bio\ufb01lms and Iron"], [[45.0, 62.0, 211, 8], "Haque, M., Sartelli, M., McKimm, J., and Bakar, M. A. (2018). Health Care-"], [[55.0, 71.0, 215, 8], "Associated Infections \u2013 An Overview. Infect. Drug Resist. 11, 2321\u20132333. doi:"], [[55.0, 81.0, 61, 8], "10.2147/IDR.S177247"], [[45.0, 91.0, 231, 8], "Hazmanian, S. K., Skaar, E. P., Gaspar, A. H., Humayun, M., Gornicki, P., Jelenska,"], [[55.0, 100.0, 212, 8], "J, et al. (2003). Passage of Heme-Iron Across the Envelope of Staphylococcus"], [[55.0, 109.0, 184, 8], "aureus. Science 299 (5608), 906\u2013909. doi: 10.1126/science.1081147"], [[45.0, 119.0, 225, 8], "Heilbronner, S., Holden, M. T. G., van Tonder, A., Geoghegan, J. A., Foster, T. J.,"], [[55.0, 129.0, 203, 8], "Parkhill, J, et al. (2011). Genome Sequence of Staphylococcus lugdunensis"], [[55.0, 137.0, 220, 8], "N920143 Allows Identi\ufb01cation of Putative Colonization and Virulence Factors."], [[55.0, 147.0, 213, 8], "FEMS Microbiol. Lett. 322 (1), 60\u201367. doi: 10.1111/j.1574-6968.2011.02339.x"], [[45.0, 157.0, 230, 8], "Heilmann, C., Schweitzer, O., Gerke, C., Vanittanakom, N., Mack, D., and G\u00f6tz, F."], [[55.0, 166.0, 204, 8], "(1996). Molecular Basis of Intercellular Adhesion in the Bio\ufb01lm-Forming"], [[55.0, 175.0, 212, 8], "Staphylococcus epidermidis. Mol. Microbiol. 20 (5), 1083\u20131091. doi: 10.1111/"], [[55.0, 186.0, 76, 8], "j.1365-2958.1996.tb02548.x"], [[45.0, 195.0, 231, 8], "Hider, R. C., and Kong, X. (2010). Chemistry and Biology of Siderophores. Natural"], [[55.0, 204.0, 148, 8], "Product. Rep. 27 (5), 637\u2013657. doi: 10.1039/b906679a"], [[45.0, 214.0, 222, 8], "Hogan, S., Stevens, N. T., Humphreys, H., Gara, J. P. O., and Neill, E. O. (2015)."], [[55.0, 224.0, 190, 8], "Current and Future Approaches to the Prevention and Treatment of"], [[55.0, 233.0, 209, 8], "Staphylococcal Medical Device-Related Infections. Curr. Pharm. Design. 21"], [[55.0, 242.0, 158, 8], "(1), 100\u2013113. doi: 10.2174/1381612820666140905123900"], [[45.0, 252.0, 198, 8], "Holden, V. I., and Bachman, M. A. (2015). Diverging Roles of Bacterial"], [[55.0, 261.0, 203, 8], "Siderophores During Infection. Metallomics 7 (6), 986\u2013995. doi: 10.1039/"], [[55.0, 271.0, 40, 8], "C4MT00333K"], [[45.0, 281.0, 229, 8], "Hudson, J. M., Heffron, K., Kotlyar, V., Sher, Y., Maklashina, E., Cecchini, G, et al."], [[55.0, 290.0, 221, 8], "(2005). Electron Transfer and Catalytic Control by the Iron-Sulfur Clusters in a"], [[55.0, 300.0, 216, 8], "Respiratory Enzyme, E. Coli Fumarate Reductase. J. Am. Chem. Soc. 127 (19),"], [[55.0, 308.0, 98, 8], "6977\u20136989. doi: 10.1021/ja043404q"], [[45.0, 319.0, 214, 8], "Ito-Horiyama, T., Ishii, Y., Ito, A., Sato, T., Nakamura, R., Fukuhara, N, et al."], [[55.0, 328.0, 199, 8], "(2016). Stability of Novel Siderophore Cephalosporin S-649266 Against"], [[55.0, 338.0, 205, 8], "Clinically Relevant Carbapenemases. Antimicrobial. Agents Chemother 60"], [[55.0, 346.0, 113, 8], "(7), 4384\u20136. doi: 10.1128/AAC.03098-15"], [[45.0, 357.0, 220, 8], "Ito, A., Kohira, N., Bouchillon, S. K., West, J., Rittenhouse, S., Sader, H. S, et al."], [[55.0, 366.0, 210, 8], "(2016). In Vitro Antimicrobial Activity of S-649266, a Catechol-Substituted"], [[55.0, 376.0, 210, 8], "Siderophore Cephalosporin, When Tested Against Non-Fermenting Gram-"], [[55.0, 384.0, 218, 8], "Negative Bacteria. J. Antimicrobial. Chemother 71 (3), 670\u20137. doi: 10.1093/jac/"], [[55.0, 395.0, 20, 8], "dkv402"], [[45.0, 404.0, 210, 8], "Ji, C., Miller, P. A., and Miller, M. J. (2012). Iron Transport-Mediated Drug"], [[55.0, 414.0, 198, 8], "Delivery: Practical Syntheses and In Vitro Antibacterial Studies of Tris-"], [[55.0, 423.0, 202, 8], "Catecholate Siderophore-Aminopenicillin Conjugates Reveals Selectively"], [[55.0, 432.0, 214, 8], "Potent Antipseudomonal Activity. J. Am. Chem. Soc 134 (24), 9898\u2013901. doi:"], [[55.0, 442.0, 54, 8], "10.1021/ja303446w"], [[45.0, 452.0, 217, 8], "Johnson, M., Cockayne, A., Williams, P. H., and Morrissey, J. A. (2005). Iron-"], [[55.0, 460.0, 219, 8], "Responsive Regulation of Bio\ufb01lm Formation in Staphylococcus aureus Involves"], [[55.0, 471.0, 203, 8], "Fur-Dependent and Fur-Independent Mechanisms. J. Bacteriol. 187 (23),"], [[55.0, 479.0, 142, 8], "8211\u20138215. doi: 10.1128/JB.187.23.8211-8215.2005"], [[45.0, 490.0, 228, 8], "Kakhlon, O., and Cabantchik, Z. I. (2002). The Labile Iron Pool: Characterization,"], [[55.0, 499.0, 217, 8], "Measurement, and Participation in Cellular Processes. Free Radical Biol. Med."], [[55.0, 508.0, 156, 8], "33 (8), 1037\u20131046. doi: 10.1016/S0891-5849(02)01006-7"], [[45.0, 518.0, 214, 8], "Kelson, A. B., Carnevali, M., and Truong-Le, V. (2013). Gallium-Based Anti-"], [[55.0, 528.0, 195, 8], "Infectives: Targeting Microbial Iron-Uptake Mechanisms. Curr. Opin."], [[55.0, 536.0, 163, 8], "Pharmacol 13 (5), 707\u201316. doi: 10.1016/j.coph.2013.07.001"], [[45.0, 547.0, 220, 8], "Kleinschmidt, S., Huygens, F., Faoagali, J., Rathnayake, I. U., and Hafner, L. M."], [[55.0, 556.0, 219, 8], "(2015). Staphylococcus epidermidis as a Cause of Bacteremia. Future Microbiol."], [[55.0, 565.0, 121, 8], "10 (11), 1859\u20131879. doi: 10.2217/fmb.15.98"], [[45.0, 575.0, 226, 8], "Kristian, S. A., Birkenstock, T. A., Sauder, U., Mack, D., G\u00f6tz, F., and Landmann,"], [[55.0, 584.0, 218, 8], "R. (2008). Bio\ufb01lm Formation Induces C3a Release and Protects Staphylococcus"], [[55.0, 594.0, 209, 8], "epidermidis From IgG and Complement Deposition and From Neutrophil-"], [[55.0, 603.0, 205, 8], "Dependent Killing. J. Infect. Dis. 197 (7), 1028\u20131035. doi: 10.1086/528992"], [[45.0, 612.0, 214, 8], "Lee, J. Y. H., Monk, I. R., Gonc\u0327alves da Silva, A., Seemann, T., Chua, K. Y. L.,"], [[55.0, 623.0, 216, 8], "Kearns, A, et al. (2018). Global Spread of Three Multidrug-Resistant Lineages"], [[55.0, 631.0, 219, 8], "of Staphylococcus epidermidis. Nat. Microbiol. 3 (10), 1175\u20131185. doi: 10.1038/"], [[55.0, 642.0, 54, 8], "s41564-018-0230-7"], [[45.0, 651.0, 244, 8], "Lin, H., Fischbach, M. A., Liu, D. R., and Walsh, C. T. (2005). In Vitro Characterization"], [[55.0, 661.0, 231, 8], "of Salmochelin and Enterobactin Trilactone Hydrolases IroD, IroE, and Fes. J. Am."], [[55.0, 669.0, 163, 8], "Chem. Soc. 127 (31), 11075\u201311084. doi: 10.1021/ja0522027"], [[45.0, 680.0, 222, 8], "Liu, J., Chakraborty, S., Hosseinzadeh, P., Yu, Y., Tian, S., Petrik, I, et al. (2014)."], [[55.0, 688.0, 201, 8], "Metalloproteins Containing Cytochrome, Iron\u2013Sulfur, or Copper Redox"], [[55.0, 698.0, 180, 8], "Centers. Chem. Rev. 114 (8), 4366\u20134469. doi: 10.1021/cr400479b"], [[306.0, 61.0, 215, 8], "Lourtet-Hasco\u00ebt, J., Bicart-See, A., Fe\u0301lice\u0301, M. P., Giordano, G., and Bonnet, E."], [[316.0, 72.0, 216, 8], "(2016). Staphylococcus lugdunensis, a Serious Pathogen in Periprosthetic Joint"], [[316.0, 81.0, 191, 8], "Infections: Comparison to Staphylococcus aureus and Staphylococcus"], [[316.0, 90.0, 194, 8], "epidermidis. Int. J. Infect. Dis 51:56\u201361. doi: 10.1016/j.ijid.2016.08.007"], [[306.0, 100.0, 233, 8], "Lyte, M., Freestone, P. P. E., Neal, C. P., Olson, B. A., Haigh, R. D., Bayston, R, et al."], [[316.0, 109.0, 195, 8], "(2003). Stimulation of Staphylococcus epidermidis Growth and Bio\ufb01lm"], [[316.0, 118.0, 209, 8], "Formation by Catecholamine Inotropes. Lancet [Internet] 361 (9352), 130\u2013"], [[316.0, 129.0, 116, 8], "135. doi: 10.1016/S0140-6736(03)12231-3"], [[306.0, 138.0, 235, 8], "Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A,"], [[316.0, 147.0, 211, 8], "et al. (2014). Multistate Point-Prevalence Survey of Health Care\u2013Associated"], [[316.0, 156.0, 226, 8], "Infections. New Engl. J. Med. 370 (13), 1198\u20131208. doi: 10.1056/NEJMoa1306801"], [[306.0, 167.0, 229, 8], "Matzanke, B. F., Anem\u00fcller, S., Sch\u00fcnemann, V., Trautwein, A. X., and Hantke, K."], [[316.0, 176.0, 210, 8], "(2004). FhuF, Part of a Siderophore-Reductase System. Biochemistry 43 (5),"], [[316.0, 185.0, 99, 8], "1386\u20131392. doi: 10.1021/bi0357661"], [[306.0, 195.0, 237, 8], "McCann, M. T., Gilmore, B. F., and Gorman, S. P. (2008). Staphylococcus epidermidis"], [[316.0, 205.0, 214, 8], "Device-Related Infections: Pathogenesis and Clinical Management. J. Pharm."], [[316.0, 213.0, 167, 8], "Pharmacol. 60 (12), 1551\u20131571. doi: 10.1211/jpp/60.12.0001"], [[306.0, 224.0, 231, 8], "Meyer, J. M., Neely, A., Stintzi, A., Georges, C., and Holder, I. A. (1996). Pyoverdin"], [[316.0, 233.0, 212, 8], "is Essential for Virulence of Pseudomonas aeruginosa. Infect. Immun. 64 (2),"], [[316.0, 242.0, 122, 8], "518\u2013523. doi: 10.1128/iai.64.2.518-523.1996"], [[306.0, 252.0, 229, 8], "Meynard, D., Babitt, J. L., and Lin, H. Y. (2014). The Liver: Conductor of Systemic"], [[316.0, 261.0, 206, 8], "Iron Balance. Blood 123 (2), 168\u2013176. doi: 10.1182/blood-2013-06-427757"], [[306.0, 271.0, 220, 8], "Miethke, M. (2013). Molecular Strategies of Microbial Iron Assimilation: From"], [[316.0, 280.0, 210, 8], "High-Af\ufb01nity Complexes to Cofactor Assembly Systems. Metallomics 5 (1),"], [[316.0, 289.0, 96, 8], "15\u201328. doi: 10.1039/C2MT20193C"], [[306.0, 300.0, 230, 8], "Monta\u00f1ez, G. E., Neely, M. N., and Eichenbaum, Z. (2005). The Streptococcal Iron"], [[316.0, 309.0, 203, 8], "Uptake (Siu) Transporter is Required for Iron Uptake and Virulence in a"], [[316.0, 318.0, 218, 8], "Zebra\ufb01sh Infection Model. Microbiology 151 (Pt 11), 3749\u20133757. doi: 10.1099/"], [[316.0, 328.0, 39, 8], "mic.0.28075-0"], [[306.0, 338.0, 232, 8], "Morgan, B., and Lahav, O. (2007). The Effect of pH on the Kinetics of Spontaneous"], [[316.0, 347.0, 211, 8], "Fe(II) Oxidation by O2 in Aqueous Solution - Basic Principles and a Simple"], [[316.0, 356.0, 185, 8], "Heuristic Description. Chemosphere 68 (11), 2080\u20134. doi: 10.1016/"], [[316.0, 366.0, 75, 8], "j.chemosphere.2007.02.015"], [[306.0, 376.0, 212, 8], "Nakaminami, H., Chen, C., Truong-Bolduc, Q. C., Kim, E. S., Wang, Y., and"], [[316.0, 384.0, 213, 8], "Hooper, D. C. (2017). Ef\ufb02ux Transporter of Siderophore Staphyloferrin A in"], [[316.0, 395.0, 199, 8], "Staphylococcus aureus Contributes to Bacterial Fitness in Abscesses and"], [[316.0, 403.0, 190, 8], "Epithelial Cells. Infect. Immun. 85 (8), e00358\u2013e00317. doi: 10.1128/"], [[316.0, 414.0, 37, 8], "IAI.00358-17"], [[306.0, 423.0, 234, 8], "Neal, C. P., Freestone, P. P. E., Maggs, A. F., Haigh, R. D., Williams, P. H., and Lyte,"], [[316.0, 433.0, 207, 8], "M. (2001). Catecholamine Inotropes as Growth Factors for Staphylococcus"], [[316.0, 442.0, 209, 8], "epidermidis and Other Coagulase-Negative Staphylococci. FEMS Microbiol."], [[316.0, 451.0, 177, 8], "Lett. 194 (2), 163\u2013169. doi: 10.1111/j.1574-6968.2001.tb09463.x"], [[306.0, 459.0, 234, 14], "Oliveira, F., Franc\u0327a, A\u0302 ., and Cerca, N. (2017). Staphylococcus epidermidis is Largely"], [[316.0, 470.0, 213, 8], "Dependent on Iron Availability to Form Bio\ufb01lms. Int. J. Med. Microbiol. 307"], [[316.0, 479.0, 128, 8], "(8), 552\u2013563. doi: 10.1016/j.ijmm.2017.08.009"], [[306.0, 490.0, 228, 8], "Oliveira, F., Lima, T., Correia, A., Silva, A. M., Soares, C., Morais, S, et al. (2021b)."], [[316.0, 498.0, 198, 8], "Siderophore-Mediated Iron Acquisition Plays a Critical Role in Bio\ufb01lm"], [[316.0, 509.0, 199, 8], "Formation and Survival of Staphylococcus epidermidis Within the Host."], [[316.0, 518.0, 151, 8], "Front. Med. 8, 799227. doi: 10.3389/fmed.2021.799227"], [[306.0, 528.0, 231, 8], "Oliveira, F., Rohde, H., Vilanova, M., and Cerca, N. (2021a). The Emerging Role of"], [[316.0, 536.0, 210, 8], "Iron Acquisition in Bio\ufb01lm-Associated Infections. Trends Microbiol. 29 (9),"], [[316.0, 546.0, 111, 8], "772\u2013775. doi: 10.1016/j.tim.2021.02.009"], [[306.0, 556.0, 226, 8], "Otto, M. (2012). Molecular Basis of Staphylococcus epidermidis Infections. Semin."], [[316.0, 565.0, 176, 8], "Immunopathol 34 (2), 201\u201314. doi: 10.1007/s00281-011-0296-2"], [[306.0, 575.0, 216, 8], "Pittet, D., Allegranzi, B., Storr, J., Nejad, S. B., Dziekan, G., Leotsakos, A, et al."], [[316.0, 585.0, 213, 8], "(2008). Infection Control as a Major World Health Organization Priority for"], [[316.0, 593.0, 189, 8], "Developing Countries. J. Hosp. Infect. 68 (4), 285\u2013292. doi: 10.1016/"], [[316.0, 604.0, 49, 8], "j.jhin.2007.12.013"], [[306.0, 613.0, 230, 8], "Porcheron, G., and Dozois, C. M. (2015). Interplay Between Iron Homeostasis and"], [[316.0, 623.0, 215, 8], "Virulence: Fur and RyhB as Major Regulators of Bacterial Pathogenicity. Vet."], [[316.0, 631.0, 170, 8], "Microbiol. 179 (1\u20132), 2\u201314. doi: 10.1016/j.vetmic.2015.03.024"], [[306.0, 642.0, 227, 8], "Rabsch, W., Methner, U., Voigt, W., Tsch\u00e4pe, H., Reissbrodt, R., and Williams, P."], [[316.0, 651.0, 174, 8], "H. (2003). Role of Receptor Proteins for Enterobactin and 2,3-"], [[316.0, 661.0, 213, 8], "Dihydroxybenzoylserine in Virulence of Salmonella Enterica. Infect. Immun."], [[316.0, 669.0, 165, 8], "71 (12), 6953\u20136956. doi: 10.1128/IAI.71.12.6953-6961.2003"], [[306.0, 680.0, 225, 8], "Raymond, K. N., Dertz, E. A., and Kim, S. S. (2003). Enterobactin: An Archetype"], [[316.0, 688.0, 211, 8], "for Microbial Iron Transport. Proc. Natl. Acad. Sci. 100 (7), 3584\u20133588. doi:"], [[316.0, 699.0, 72, 8], "10.1073/pnas.0630018100"], [[45.0, 743.0, 171, 7], "Frontiers in Cellular and Infection Microbiology | www.frontiersin.org"], [[295.0, 743.0, 3, 7], "7"], [[408.0, 743.0, 115, 7], "November 2021 | Volume 11 | Article 798563"]], [779, 595]], [8, [[[45.0, 30.0, 32, 7], "Oliveira et al."], [[399.0, 30.0, 129, 7], "Interplay Between S. epidermidis Bio\ufb01lms and Iron"], [[45.0, 62.0, 226, 8], "Reddy, P. V., Puri, R. V., Chauhan, P., Kar, R., Rohilla, A., Khera, A, et al. (2013)."], [[55.0, 72.0, 177, 8], "Disruption of Mycobactin Biosynthesis Leads to Attenuation of"], [[55.0, 81.0, 213, 8], "Mycobacterium tuberculosis for Growth and Virulence. J. Infect. Dis. 208 (8),"], [[55.0, 90.0, 104, 8], "1255\u20131265. doi: 10.1093/infdis/jit250"], [[45.0, 100.0, 224, 8], "Richter, K., Ramezanpour, M., Thomas, N., Prestidge, C. A., Wormald, P. J., and"], [[55.0, 109.0, 207, 8], "Vreugde, S. (2016). Mind \u201cDe GaPP\u201d: In Vitro Ef\ufb01cacy of Deferiprone and"], [[55.0, 118.0, 215, 8], "Gallium-Protoporphyrin Against Staphylococcus aureus Bio\ufb01lms. Int. Forum"], [[55.0, 128.0, 143, 8], "Allergy Rhinol 6 (7), 737\u201343. doi: 10.1002/alr.21735"], [[45.0, 138.0, 227, 8], "Richter, K., Thomas, N., Claeys, J., McGuane, J., Prestidge, C. A., Coenye, T, et al."], [[55.0, 148.0, 215, 8], "(2017b). A Topical Hydrogel With Deferiprone and Gallium-Protoporphyrin"], [[55.0, 156.0, 220, 8], "Targets Bacterial Iron Metabolism and has Antibio\ufb01lm Activity. Antimicrobial."], [[55.0, 166.0, 183, 8], "Agents Chemother 61 (6), e00481\u201317. doi: 10.1128/AAC.00481-17"], [[45.0, 176.0, 221, 8], "Richter, K., Thomas, N., Zhang, G., Prestidge, C. A., Coenye, T., Wormald, P. J,"], [[55.0, 186.0, 217, 8], "et al. (2017a). Deferiprone and Gallium-Protoporphyrin Have the Capacity to"], [[55.0, 195.0, 212, 8], "Potentiate the Activity of Antibiotics in Staphylococcus aureus Small Colony"], [[55.0, 205.0, 212, 8], "Variants. Front. Cell. Infect. Microbiol 7, 280. doi: 10.3389/fcimb.2017.00280"], [[45.0, 214.0, 218, 8], "Rohde, H., Burdelski, C., Bartscht, K., Hussain, M., Buck, F., Horstkotte, M. A,"], [[55.0, 223.0, 211, 8], "et al. (2005). Induction of Staphylococcus epidermidis Bio\ufb01lm Formation via"], [[55.0, 233.0, 184, 8], "Proteolytic Processing of the Accumulation-Associated Protein by"], [[55.0, 242.0, 208, 8], "Staphylococcal and Host Proteases. Mol. Microbiol. 55 (6), 1883\u20131895. doi:"], [[55.0, 252.0, 95, 8], "10.1111/j.1365-2958.2005.04515.x"], [[45.0, 261.0, 229, 8], "Rossi, M. S., Fetherston, J. D., Le\u0301toffe\u0301, S., Carniel, E., Perry, R. D., and Ghigo, J. M."], [[55.0, 270.0, 206, 8], "(2001). Identi\ufb01cation and Characterization of the Hemophore-Dependent"], [[55.0, 280.0, 206, 8], "Heme Acquisition System of Yersinia pestis. Infect. Immun 69 (11), 6707\u2013"], [[55.0, 290.0, 125, 8], "6717. doi: 10.1128/IAI.69.11.6707-6717.2001"], [[45.0, 300.0, 215, 8], "Runci, F., Gentile, V., Frangipani, E., Rampioni, G., Leoni, L., Lucidi, M, et al."], [[55.0, 309.0, 200, 8], "(2019). Contribution of Active Iron Uptake to Acinetobacter baumannii"], [[55.0, 319.0, 200, 8], "Pathogenicity. Infect. Immun. 87 (4), e00755. doi: 10.1128/IAI.00755-18"], [[45.0, 328.0, 222, 8], "Schommer, N. N., Christner, M., Hentschke, M., Ruckdeschel, K., Aepfelbacher,"], [[55.0, 338.0, 188, 8], "M., and Rohde, H. (2011). Staphylococcus epidermidis Uses Distinct"], [[55.0, 346.0, 198, 8], "Mechanisms of Bio\ufb01lm Formation To Interfere With Phagocytosis and"], [[55.0, 357.0, 211, 8], "Activation of Mouse Macrophage-Like Cells J774A.1. Infect. Immun. 79 (6),"], [[55.0, 365.0, 107, 8], "2267\u20132276. doi: 10.1128/IAI.01142-10"], [[45.0, 375.0, 230, 8], "Schwertmann, U. (1991). \u201cSolubility and Dissolution of Iron Oxides,\u201d in Plant and"], [[55.0, 384.0, 29, 8], "Soil, 1\u201325."], [[45.0, 395.0, 218, 8], "Sheldon, J. R., and Heinrichs, D. E. (2012). The Iron-Regulated Staphylococcal"], [[55.0, 404.0, 189, 8], "Lipoproteins. Front. Cell. Infect. Microbiol. 2(2235-2988 (2235-2988"], [[55.0, 414.0, 132, 8], "(Electronic), 41. doi: 10.3389/fcimb.2012.00041"], [[45.0, 423.0, 219, 8], "Singh, R., Sahore, S., Kaur, P., Rani, A., and Ray, P. (2016). Penetration Barrier"], [[55.0, 432.0, 208, 8], "Contributes to Bacterial Bio\ufb01lm-Associated Resistance Against Only Select"], [[55.0, 441.0, 214, 8], "Antibiotics, and Exhibits Genus-, Strain- and Antibiotic-Speci\ufb01c Differences."], [[55.0, 452.0, 155, 8], "Pathog. Dis. 74 (6), ftw056. doi: 10.1093/femspd/ftw056"], [[45.0, 461.0, 218, 8], "Skaar, E. P. (2010). The Battle for Iron Between Bacterial Pathogens and Their"], [[55.0, 471.0, 169, 8], "Vertebrate Hosts. PloS Pathog. 6 (8), e1000949. doi: 10.1371/"], [[55.0, 480.0, 59, 8], "journal.ppat.1000949"], [[45.0, 490.0, 202, 8], "Soares, M. P., and Hamza, I. (2016). Macrophages and Iron Metabolism."], [[55.0, 498.0, 173, 8], "Immunity 44 (3), 492\u2013504. doi: 10.1016/j.immuni.2016.02.016"], [[45.0, 508.0, 213, 8], "Syntiron, Sano\ufb01 Pasteur. (2018) Research Programme: Staphylococcus aureus"], [[55.0, 517.0, 211, 8], "Vaccine - Syntiron/sano\ufb01 Pasteur. Available at: https://adisinsight.springer."], [[55.0, 528.0, 64, 8], "com/drugs/800031401."], [[45.0, 537.0, 227, 8], "Takase, H., Nitanai, H., Hoshino, K., and Otani, T. (2000). Impact of Siderophore"], [[55.0, 547.0, 205, 8], "Production on Pseudomonas aeruginosa Infections in Immunosuppressed"], [[55.0, 555.0, 218, 8], "Mice. Infect. Immun. 68 (4), 1834\u20131839. doi: 10.1128/IAI.68.4.1834-1839.2000"], [[45.0, 566.0, 224, 8], "Taylor, J. M., and Heinrichs, D. E. (2002). Transferrin Binding in Staphylococcus"], [[55.0, 575.0, 214, 8], "aureus: Involvement of a Cell Wall-Anchored Protein. Mol. Microbiol 43 (6),"], [[55.0, 584.0, 140, 8], "1603\u20131614. doi: 10.1046/j.1365-2958.2002.02850.x"], [[45.0, 594.0, 214, 8], "Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., and Fowler, V. G."], [[55.0, 604.0, 205, 8], "(2015). Staphylococcus aureus Infections: Epidemiology, Pathophysiology,"], [[316.0, 61.0, 210, 8], "Clinical Manifestations, and Management. Clin. Microbiol. Rev 28 (3), 603\u2013"], [[316.0, 72.0, 92, 8], "661. doi: 10.1128/CMR.00134-14"], [[306.0, 81.0, 223, 8], "Torres, V. J., Attia, A. S., Mason, W. J., Hood, M. I., Corbin, B. D., Beasley, F. C,"], [[316.0, 91.0, 216, 8], "et al. (2010). Staphylococcus aureus Fur Regulates the Expression of Virulence"], [[316.0, 100.0, 217, 8], "Factors That Contribute to the Pathogenesis of Pneumonia. Infect. Immun. 78"], [[316.0, 109.0, 118, 8], "(4), 1618\u20131628. doi: 10.1128/IAI.01423-09"], [[306.0, 119.0, 211, 8], "Torres, V. J., Pishchany, G., Humayun, M., Schneewind, O., and Skaar, E. P."], [[316.0, 129.0, 208, 8], "(2006). Staphylococcus aureus IsdB is a Hemoglobin Receptor Required for"], [[316.0, 137.0, 195, 8], "Heme Iron Utilization. J. Bacteriol. 188 (24), 8421\u20138429. doi: 10.1128/"], [[316.0, 148.0, 34, 8], "JB.01335-06"], [[306.0, 157.0, 209, 8], "Troxell, B., and Hassan, H. M. (2013). Transcriptional Regulation by Ferric"], [[316.0, 166.0, 213, 8], "Uptake Regulator (Fur) in Pathogenic Bacteria. Front. Cell. Infect. Microbiol."], [[316.0, 176.0, 102, 8], "3, 59. doi: 10.3389/fcimb.2013.00059"], [[306.0, 186.0, 224, 8], "Troxell, B., Xu, H., and Yang, X. F. (2012). Borrelia burgdorferi, a Pathogen That"], [[316.0, 195.0, 213, 8], "Lacks Iron, Encodes Manganese-Dependent Superoxide Dismutase Essential"], [[316.0, 204.0, 205, 8], "for Resistance to Streptonigrin. J. Biol. Chem. 287 (23), 19284\u201319293. doi:"], [[316.0, 214.0, 71, 8], "10.1074/jbc.M112.344903"], [[306.0, 224.0, 229, 8], "Vincent, J. L. (2003). Nosocomial Infections in Adult Intensive-Care Units. Lancet"], [[316.0, 232.0, 150, 8], "361, 2068\u20132077. doi: 10.1016/S0140-6736(03)13644-6"], [[306.0, 243.0, 231, 8], "Waldvogel-Abramowski, S., Waeber, G., Gassner, C., Buser, A., Frey, B. M., Favrat,"], [[316.0, 252.0, 215, 8], "B, et al. (2014). Physiology of Iron Metabolism. Transfusion. Med. Hemother."], [[316.0, 261.0, 113, 8], "41 (3), 213\u2013221. doi: 10.1159/000362888"], [[306.0, 271.0, 196, 8], "Wencewicz, T. A., Long, T. E., M\u00f6llmann, U., and Miller, M. J. (2013)."], [[316.0, 281.0, 199, 8], "Trihydroxamate Siderophore-Fluoroquinolone Conjugates are Selective"], [[316.0, 290.0, 207, 8], "Sideromycin Antibiotics That Target Staphylococcus aureus. Bioconjugate."], [[316.0, 299.0, 131, 8], "Chem. 24 (3), 473\u2013486. doi: 10.1021/bc300610f"], [[306.0, 309.0, 225, 8], "Wilson, B. R., Bogdan, A. R., Miyazawa, M., Hashimoto, K., and Tsuji, Y. (2016)."], [[316.0, 319.0, 206, 8], "Siderophores in Iron Metabolism: From Mechanism to Therapy Potential."], [[316.0, 327.0, 205, 8], "Trends Mol. Med. 22 (12), 1077\u20131090. doi: 10.1016/j.molmed.2016.10.005"], [[306.0, 338.0, 226, 8], "Zarb, P., Coignard, B., Griskeviciene, J., Muller, A., Vankerckhoven, V., Weist, K,"], [[316.0, 347.0, 197, 8], "et al. (2012). The European Centre for Disease Prevention and Control"], [[316.0, 357.0, 208, 8], "(ECDC) Pilot Point Prevalence Survey of Healthcare-Associated Infections"], [[316.0, 366.0, 194, 8], "and Antimicrobial Use. Eurosurveillance 17 (46), 20316. doi: 10.2807/"], [[316.0, 376.0, 52, 8], "ese.17.46.20316-en"], [[306.0, 384.0, 209, 8], "Zhang, A. S., and Enns, C. A. (2009). Iron Homeostasis: Recently Identi\ufb01ed"], [[316.0, 395.0, 213, 8], "Proteins Provide Insight Into Novel Control Mechanisms. J. Biol. Chem. 284"], [[316.0, 403.0, 119, 8], "(2), 711\u2013715. doi: 10.1074/jbc.R800017200"], [[306.0, 414.0, 230, 8], "Ziebuhr, W., Heilmann, C., G\u00f6tz, F., Meyer, P., Wilms, K., Straube, E, et al. (1997)."], [[316.0, 423.0, 221, 8], "Detection of the Intercellular Adhesion Gene Cluster (Ica) and Phase Variation"], [[316.0, 433.0, 206, 8], "in Staphylococcus epidermidis Blood Culture Strains and Mucosal Isolates."], [[316.0, 441.0, 185, 8], "Infect. Immun. 65 (3), 890\u2013896. doi: 10.1128/iai.65.3.890-896.1997"], [[306.0, 459.0, 224, 8], "Con\ufb02ict of Interest: The authors declare that the research was conducted in the"], [[306.0, 468.0, 226, 8], "absence of any commercial or \ufb01nancial relationships that could be construed as a"], [[306.0, 478.0, 78, 8], "potential con\ufb02ict of interest."], [[306.0, 497.0, 232, 8], "Publisher\u2019s Note: All claims expressed in this article are solely those of the authors"], [[306.0, 507.0, 227, 8], "and do not necessarily represent those of their af\ufb01liated organizations, or those of"], [[306.0, 517.0, 229, 8], "the publisher, the editors and the reviewers. Any product that may be evaluated in"], [[306.0, 526.0, 223, 8], "this article, or claim that may be made by its manufacturer, is not guaranteed or"], [[306.0, 536.0, 74, 8], "endorsed by the publisher."], [[306.0, 556.0, 234, 8], "Copyright \u00a9 2021 Oliveira, Rohde, Vilanova and Cerca. This is an open-access article"], [[306.0, 566.0, 228, 8], "distributed under the terms of the Creative Commons Attribution License (CC BY)."], [[306.0, 575.0, 217, 8], "The use, distribution or reproduction in other forums is permitted, provided the"], [[306.0, 585.0, 217, 8], "original author(s) and the copyright owner(s) are credited and that the original"], [[306.0, 594.0, 235, 8], "publication in this journal is cited, in accordance with accepted academic practice. No"], [[306.0, 604.0, 235, 8], "use, distribution or reproduction is permitted which does not comply with these terms."], [[45.0, 743.0, 171, 7], "Frontiers in Cellular and Infection Microbiology | www.frontiersin.org"], [[295.0, 743.0, 3, 7], "8"], [[408.0, 743.0, 115, 7], "November 2021 | Volume 11 | Article 798563"]], [779, 595]]]